><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulson</surname><given-names>T</given-names></name></person-group>
<article-title>Epidemiology: a mortal foe</article-title>. <source>Nature</source> (<year>2013</year>) <volume>502</volume>:<fpage>S2</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/502S2a</pub-id><pub-id pub-id-type="pmid">24108078</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mobley</surname><given-names>JL</given-names></name></person-group>. <article-title>Is rheumatoid arthritis a consequence of natural selection for enhanced tuberculosis resistance?</article-title>
<source>Med Hypotheses</source> (<year>2004</year>) <volume>62</volume>:<fpage>839</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.mehy.2003.12.006</pub-id><?supplied-pmid 15082117?><pub-id pub-id-type="pmid">15082117</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>PA</given-names></name><name><surname>Gomez</surname><given-names>LM</given-names></name><name><surname>Cadena</surname><given-names>J</given-names></name><name><surname>Anaya</surname><given-names>JM</given-names></name></person-group>. <article-title>Autoimmunity and tuberculosis. Opposite association with TNF polymorphism</article-title>. <source>J Rheumatol</source> (<year>2005</year>) <volume>32</volume>:<fpage>219</fpage>&#x02013;<lpage>24</lpage>.<?supplied-pmid 15693080?><pub-id pub-id-type="pmid">15693080</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boum</surname><given-names>Y</given-names><suffix>II</suffix></name><name><surname>Atwine</surname><given-names>D</given-names></name><name><surname>Orikiriza</surname><given-names>P</given-names></name><name><surname>Assimwe</surname><given-names>J</given-names></name><name><surname>Page</surname><given-names>AL</given-names></name><name><surname>Mwanga-Amumpaire</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Male Gender is independently associated with pulmonary tuberculosis among sputum and non-sputum producers people with presumptive tuberculosis in Southwestern Uganda</article-title>. <source>BMC Infect Dis</source> (<year>2014</year>) <volume>14</volume>:<fpage>638</fpage>.<pub-id pub-id-type="doi">10.1186/s12879-014-0638-5</pub-id><?supplied-pmid 25492725?><pub-id pub-id-type="pmid">25492725</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairweather</surname><given-names>D</given-names></name><name><surname>Frisancho-Kiss</surname><given-names>S</given-names></name><name><surname>Rose</surname><given-names>NR</given-names></name></person-group>. <article-title>Sex differences in autoimmune disease from a pathological perspective</article-title>. <source>Am J Pathol</source> (<year>2008</year>) <volume>173</volume>:<fpage>600</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2008.071008</pub-id><?supplied-pmid 18688037?><pub-id pub-id-type="pmid">18688037</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strachan</surname><given-names>DP</given-names></name></person-group>
<article-title>Hay fever, hygiene, and household size</article-title>. <source>BMJ</source> (<year>1989</year>) <volume>299</volume>:<fpage>1259</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1136/bmj.299.6710.1259</pub-id><pub-id pub-id-type="pmid">2513902</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Kuhn</surname><given-names>C</given-names></name><name><surname>Feillet</surname><given-names>H</given-names></name><name><surname>Bach</surname><given-names>JF</given-names></name></person-group>. <article-title>The &#x02018;hygiene hypothesis&#x02019; for autoimmune and allergic diseases: an update</article-title>. <source>Clin Exp Immunol</source> (<year>2010</year>) <volume>160</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04139.x</pub-id><?supplied-pmid 20415844?><pub-id pub-id-type="pmid">20415844</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>JF</given-names></name></person-group>
<article-title>The effect of infections on susceptibility to autoimmune and allergic diseases</article-title>. <source>N Engl J Med</source> (<year>2002</year>) <volume>347</volume>:<fpage>911</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMra020100</pub-id><pub-id pub-id-type="pmid">12239261</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>Y</given-names></name><name><surname>Agmon-Levin</surname><given-names>N</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic>, autoimmunity, and vitamin D</article-title>. <source>Clin Rev Allergy Immunol</source> (<year>2010</year>) <volume>38</volume>:<fpage>169</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1007/s12016-009-8150-1</pub-id><?supplied-pmid 19543859?><pub-id pub-id-type="pmid">19543859</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkington</surname><given-names>P</given-names></name><name><surname>Tebruegge</surname><given-names>M</given-names></name><name><surname>Mansour</surname><given-names>S</given-names></name></person-group>. <article-title>Tuberculosis: an infection-initiated autoimmune disease?</article-title>
<source>Trends Immunol</source> (<year>2016</year>) <volume>37</volume>:<fpage>815</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2016.09.007</pub-id><?supplied-pmid 27773684?><pub-id pub-id-type="pmid">27773684</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkayam</surname><given-names>O</given-names></name><name><surname>Caspi</surname><given-names>D</given-names></name><name><surname>Lidgi</surname><given-names>M</given-names></name><name><surname>Segal</surname><given-names>R</given-names></name></person-group>. <article-title>Auto-antibody profiles in patients with active pulmonary tuberculosis</article-title>. <source>Int J Tuberc Lung Dis</source> (<year>2007</year>) <volume>11</volume>:<fpage>306</fpage>&#x02013;<lpage>10</lpage>.<?supplied-pmid 17352097?><pub-id pub-id-type="pmid">17352097</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>CY</given-names></name><name><surname>Hsieh</surname><given-names>SC</given-names></name><name><surname>Yu</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Yu</surname><given-names>CJ</given-names></name></person-group>. <article-title>Autoantibody prevalence in active tuberculosis: reactive or pathognomonic?</article-title>
<source>BMJ Open</source> (<year>2013</year>) <volume>3</volume>:<fpage>e002665</fpage>.<pub-id pub-id-type="doi">10.1136/bmjopen-2013-002665</pub-id><?supplied-pmid 23892369?><pub-id pub-id-type="pmid">23892369</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Mcnab</surname><given-names>FW</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name></person-group>. <article-title>The immune response in tuberculosis</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>475</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id><?supplied-pmid 23516984?><pub-id pub-id-type="pmid">23516984</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyadova</surname><given-names>IV</given-names></name><name><surname>Panteleev</surname><given-names>AV</given-names></name></person-group>. <article-title>Th1 and Th17&#x02009;cells in tuberculosis: protection, pathology, and biomarkers</article-title>. <source>Mediators Inflamm</source> (<year>2015</year>) <volume>2015</volume>:<fpage>854507</fpage>.<pub-id pub-id-type="doi">10.1155/2015/854507</pub-id><?supplied-pmid 26640327?><pub-id pub-id-type="pmid">26640327</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F</given-names></name><name><surname>Mayer-Barber</surname><given-names>K</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>O&#x02019;garra</surname><given-names>A</given-names></name></person-group>. <article-title>Type I interferons in infectious disease</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>87</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nri3787</pub-id><?supplied-pmid 25614319?><pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Pietra</surname><given-names>G</given-names></name><name><surname>Sullivan</surname><given-names>LC</given-names></name><name><surname>Brooks</surname><given-names>AG</given-names></name><name><surname>Prezzemolo</surname><given-names>T</given-names></name><name><surname>La Manna</surname><given-names>MP</given-names></name><etal/></person-group>
<article-title>Human CD8 T lymphocytes recognize <italic>Mycobacterium tuberculosis</italic> antigens presented by HLA-E during active tuberculosis and express type 2 cytokines</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>45</volume>:<fpage>1069</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201445193</pub-id><?supplied-pmid 25631937?><pub-id pub-id-type="pmid">25631937</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Uldrich</surname><given-names>AP</given-names></name><name><surname>Mccluskey</surname><given-names>J</given-names></name><name><surname>Rossjohn</surname><given-names>J</given-names></name><name><surname>Moody</surname><given-names>DB</given-names></name></person-group>. <article-title>The burgeoning family of unconventional T cells</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<fpage>1114</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3298</pub-id><?supplied-pmid 26482978?><pub-id pub-id-type="pmid">26482978</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Dieli</surname><given-names>F</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name></person-group>. <article-title>Human CD8+ T-cells recognizing peptides from <italic>Mycobacterium tuberculosis</italic> (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset</article-title>. <source>PLoS Pathog</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004671</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004671</pub-id><?supplied-pmid 25803478?><pub-id pub-id-type="pmid">25803478</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axtell</surname><given-names>RC</given-names></name><name><surname>De Jong</surname><given-names>BA</given-names></name><name><surname>Boniface</surname><given-names>K</given-names></name><name><surname>Van Der Voort</surname><given-names>LF</given-names></name><name><surname>Bhat</surname><given-names>R</given-names></name><name><surname>De Sarno</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis</article-title>. <source>Nat Med</source> (<year>2010</year>) <volume>16</volume>:<fpage>406</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1038/nm.2110</pub-id><?supplied-pmid 20348925?><pub-id pub-id-type="pmid">20348925</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brkic</surname><given-names>Z</given-names></name><name><surname>Corneth</surname><given-names>OB</given-names></name><name><surname>Van Helden-Meeuwsen</surname><given-names>CG</given-names></name><name><surname>Dolhain</surname><given-names>RJ</given-names></name><name><surname>Maria</surname><given-names>NI</given-names></name><name><surname>Paulissen</surname><given-names>SM</given-names></name><etal/></person-group>
<article-title>T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?</article-title>
<source>Arthritis Res Ther</source> (<year>2014</year>) <volume>16</volume>:<fpage>R62</fpage>.<pub-id pub-id-type="doi">10.1186/ar4499</pub-id><?supplied-pmid 24598455?><pub-id pub-id-type="pmid">24598455</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>P</given-names></name><name><surname>Rodriguez-Carrio</surname><given-names>J</given-names></name><name><surname>Caminal-Montero</surname><given-names>L</given-names></name><name><surname>Mozo</surname><given-names>L</given-names></name><name><surname>Suarez</surname><given-names>A</given-names></name></person-group>
<article-title>A pathogenic IFNalpha, BLyS and IL-17 axis in systemic lupus erythematosus patients</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>20651</fpage><pub-id pub-id-type="doi">10.1038/srep20651</pub-id><pub-id pub-id-type="pmid">26847824</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosset</surname><given-names>J</given-names></name></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> in the extracellular compartment: an underestimated adversary</article-title>. <source>Antimicrob Agents Chemother</source> (<year>2003</year>) <volume>47</volume>:<fpage>833</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.47.3.833-836.2003</pub-id><pub-id pub-id-type="pmid">12604509</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scordo</surname><given-names>JM</given-names></name><name><surname>Knoell</surname><given-names>DL</given-names></name><name><surname>Torrelles</surname><given-names>JB</given-names></name></person-group>. <article-title>Alveolar epithelial cells in <italic>Mycobacterium tuberculosis</italic> infection: active players or innocent bystanders?</article-title>
<source>J Innate Immun</source> (<year>2016</year>) <volume>8</volume>:<fpage>3</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1159/000439275</pub-id><?supplied-pmid 26384325?><pub-id pub-id-type="pmid">26384325</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repasy</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Marino</surname><given-names>S</given-names></name><name><surname>Martinez</surname><given-names>N</given-names></name><name><surname>Kirschner</surname><given-names>DE</given-names></name><name><surname>Hendricks</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Intracellular bacillary burden reflects a burst size for <italic>Mycobacterium tuberculosis</italic> in vivo</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003190</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003190</pub-id><?supplied-pmid 23436998?><pub-id pub-id-type="pmid">23436998</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Linas</surname><given-names>B</given-names></name><name><surname>Trevejo-Nunez</surname><given-names>GJ</given-names></name><name><surname>Kincaid</surname><given-names>E</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> infects dendritic cells with high frequency and impairs their function in vivo</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>2509</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2509</pub-id><?supplied-pmid 17675513?><pub-id pub-id-type="pmid">17675513</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaler</surname><given-names>CR</given-names></name><name><surname>Horvath</surname><given-names>CN</given-names></name><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name></person-group>. <article-title>Within the Enemy&#x02019;s Camp: contribution of the granuloma to the dissemination, persistence and transmission of <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<fpage>30</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2013.00030</pub-id><?supplied-pmid 23420646?><pub-id pub-id-type="pmid">23420646</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>CS</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>765</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3489</pub-id><?supplied-pmid 27328006?><pub-id pub-id-type="pmid">27328006</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name><name><surname>Piehler</surname><given-names>J</given-names></name></person-group>
<article-title>The molecular basis for functional plasticity in type I interferon signaling</article-title>. <source>Trends Immunol</source> (<year>2015</year>) <volume>36</volume>:<fpage>139</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2015.01.002</pub-id><pub-id pub-id-type="pmid">25687684</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coscolla</surname><given-names>M</given-names></name><name><surname>Copin</surname><given-names>R</given-names></name><name><surname>Sutherland</surname><given-names>J</given-names></name><name><surname>Gehre</surname><given-names>F</given-names></name><name><surname>De Jong</surname><given-names>B</given-names></name><name><surname>Owolabi</surname><given-names>O</given-names></name><etal/></person-group>
<article-title><italic>M. tuberculosis</italic> T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>18</volume>:<fpage>538</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.10.008</pub-id><?supplied-pmid 26607161?><pub-id pub-id-type="pmid">26607161</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Brewer</surname><given-names>TF</given-names></name><name><surname>Berkey</surname><given-names>CS</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Burdick</surname><given-names>E</given-names></name><name><surname>Fineberg</surname><given-names>HV</given-names></name><etal/></person-group>
<article-title>Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature</article-title>. <source>JAMA</source> (<year>1994</year>) <volume>271</volume>:<fpage>698</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1001/jama.271.9.698</pub-id><?supplied-pmid 8309034?><pub-id pub-id-type="pmid">8309034</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tameris</surname><given-names>MD</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Landry</surname><given-names>BS</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Snowden</surname><given-names>MA</given-names></name><name><surname>Lockhart</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial</article-title>. <source>Lancet</source> (<year>2013</year>) <volume>381</volume>:<fpage>1021</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60177-4</pub-id><?supplied-pmid 23391465?><pub-id pub-id-type="pmid">23391465</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndiaye</surname><given-names>BP</given-names></name><name><surname>Thienemann</surname><given-names>F</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Landry</surname><given-names>BS</given-names></name><name><surname>Camara</surname><given-names>M</given-names></name><name><surname>Dieye</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial</article-title>. <source>Lancet Respir Med</source> (<year>2015</year>) <volume>3</volume>:<fpage>190</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-2600(15)00037-5</pub-id><?supplied-pmid 25726088?><pub-id pub-id-type="pmid">25726088</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>S</given-names></name><name><surname>Kauffman</surname><given-names>KD</given-names></name><name><surname>Sallin</surname><given-names>MA</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Young</surname><given-names>HA</given-names></name><name><surname>Ganusov</surname><given-names>VV</given-names></name><etal/></person-group>
<article-title>CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary <italic>Mycobacterium tuberculosis</italic> infection and must be actively repressed by PD-1 to prevent lethal disease</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005667</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005667</pub-id><pub-id pub-id-type="pmid">27244558</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazar-Molnar</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Sweeney</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>EJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>13402</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1007394107</pub-id><?supplied-pmid 20624978?><pub-id pub-id-type="pmid">20624978</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group>. <article-title>CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>1598</fpage>&#x02013;<lpage>607</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003304</pub-id><?supplied-pmid 21172867?><pub-id pub-id-type="pmid">21172867</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>G</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name></person-group>. <article-title>In vitro differentiation of human macrophages with enhanced antimycobacterial activity</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<fpage>3889</fpage>&#x02013;<lpage>901</lpage>.<pub-id pub-id-type="doi">10.1172/JCI57235</pub-id><?supplied-pmid 21911939?><pub-id pub-id-type="pmid">21911939</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manry</surname><given-names>J</given-names></name><name><surname>Laval</surname><given-names>G</given-names></name><name><surname>Patin</surname><given-names>E</given-names></name><name><surname>Fornarino</surname><given-names>S</given-names></name><name><surname>Itan</surname><given-names>Y</given-names></name><name><surname>Fumagalli</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Evolutionary genetic dissection of human interferons</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<fpage>2747</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20111680</pub-id><?supplied-pmid 22162829?><pub-id pub-id-type="pmid">22162829</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivashkiv</surname><given-names>LB</given-names></name><name><surname>Donlin</surname><given-names>LT</given-names></name></person-group>. <article-title>Regulation of type I interferon responses</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>36</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1038/nri3581</pub-id><?supplied-pmid 24362405?><pub-id pub-id-type="pmid">24362405</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group>. <article-title>Type I interferon: friend or foe?</article-title>
<source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>2053</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20101664</pub-id><?supplied-pmid 20837696?><pub-id pub-id-type="pmid">20837696</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>C</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>. <article-title>Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections</article-title>. <source>Immunol Res</source> (<year>2013</year>) <volume>55</volume>:<fpage>187</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="doi">10.1007/s12026-012-8362-y</pub-id><?supplied-pmid 22983898?><pub-id pub-id-type="pmid">22983898</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshleman</surname><given-names>EM</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>. <article-title>Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>431</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00431</pub-id><?supplied-pmid 25309533?><pub-id pub-id-type="pmid">25309533</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name></person-group>. <article-title>Alveolar macrophages and type I IFN in airway homeostasis and immunity</article-title>. <source>Trends Immunol</source> (<year>2015</year>) <volume>36</volume>:<fpage>307</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2015.03.005</pub-id><?supplied-pmid 25843635?><pub-id pub-id-type="pmid">25843635</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>CR</given-names></name><name><surname>Champhekar</surname><given-names>A</given-names></name><name><surname>Tullius</surname><given-names>MV</given-names></name><name><surname>Dillon</surname><given-names>BJ</given-names></name><name><surname>Zhen</surname><given-names>A</given-names></name><name><surname>De La Fuente</surname><given-names>JR</given-names></name><etal/></person-group>
<article-title>Type I and type II interferon coordinately regulate suppressive dendritic cell fate and function during viral persistence</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005356</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005356</pub-id><?supplied-pmid 26808628?><pub-id pub-id-type="pmid">26808628</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zitvogel</surname><given-names>L</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Kepp</surname><given-names>O</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group>. <article-title>Type I interferons in anticancer immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>405</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1038/nri3845</pub-id><?supplied-pmid 26027717?><pub-id pub-id-type="pmid">26027717</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Alemanno</surname><given-names>L</given-names></name><name><surname>Galluccio</surname><given-names>G</given-names></name><name><surname>Mattia</surname><given-names>P</given-names></name><name><surname>Pedicelli</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1998</year>) <volume>158</volume>:<fpage>1156</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.158.4.9803065</pub-id><?supplied-pmid 9769275?><pub-id pub-id-type="pmid">9769275</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmero</surname><given-names>D</given-names></name><name><surname>Eiguchi</surname><given-names>K</given-names></name><name><surname>Rendo</surname><given-names>P</given-names></name><name><surname>Castro Zorrilla</surname><given-names>L</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>Gonzalez Montaner</surname><given-names>LJ</given-names></name></person-group>. <article-title>Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up</article-title>. <source>Int J Tuberc Lung Dis</source> (<year>1999</year>) <volume>3</volume>:<fpage>214</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 10094322?><pub-id pub-id-type="pmid">10094322</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Ameglio</surname><given-names>F</given-names></name><name><surname>Zangrilli</surname><given-names>P</given-names></name><name><surname>Palla</surname><given-names>M</given-names></name><name><surname>Altieri</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis</article-title>. <source>Eur Cytokine Netw</source> (<year>2000</year>) <volume>11</volume>:<fpage>99</fpage>&#x02013;<lpage>104</lpage>.<?supplied-pmid 10705306?><pub-id pub-id-type="pmid">10705306</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansoori</surname><given-names>D</given-names></name><name><surname>Tavana</surname><given-names>S</given-names></name><name><surname>Mirsaeidi</surname><given-names>M</given-names></name><name><surname>Yazdanpanah</surname><given-names>M</given-names></name><name><surname>Sohrabpour</surname><given-names>H</given-names></name></person-group>
<article-title>The efficacy of interferon-&#x003b1; in the treatment of multidrug resistant tuberculosis</article-title>. <source>Tanaffos</source> (<year>2002</year>) <volume>1</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarogoulidis</surname><given-names>P</given-names></name><name><surname>Kioumis</surname><given-names>I</given-names></name><name><surname>Papanas</surname><given-names>N</given-names></name><name><surname>Manika</surname><given-names>K</given-names></name><name><surname>Kontakiotis</surname><given-names>T</given-names></name><name><surname>Papagianis</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature</article-title>. <source>J Chemother</source> (<year>2012</year>) <volume>24</volume>:<fpage>173</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1179/1973947812Y.0000000005</pub-id><?supplied-pmid 22759763?><pub-id pub-id-type="pmid">22759763</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbatani</surname><given-names>S</given-names></name><name><surname>Manfredi</surname><given-names>R</given-names></name><name><surname>Marinacci</surname><given-names>G</given-names></name><name><surname>Pavoni</surname><given-names>M</given-names></name><name><surname>Cristoni</surname><given-names>L</given-names></name><name><surname>Chiodo</surname><given-names>F</given-names></name></person-group>. <article-title>Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis</article-title>. <source>Scand J Infect Dis</source> (<year>2006</year>) <volume>38</volume>:<fpage>205</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1080/00365540500263268</pub-id><?supplied-pmid 16500782?><pub-id pub-id-type="pmid">16500782</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farah</surname><given-names>R</given-names></name><name><surname>Awad</surname><given-names>J</given-names></name></person-group>. <article-title>The association of interferon with the development of pulmonary tuberculosis</article-title>. <source>Int J Clin Pharmacol Ther</source> (<year>2007</year>) <volume>45</volume>:<fpage>598</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="doi">10.5414/CPP45598</pub-id><?supplied-pmid 18077924?><pub-id pub-id-type="pmid">18077924</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telesca</surname><given-names>C</given-names></name><name><surname>Angelico</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>P</given-names></name><name><surname>Nosotti</surname><given-names>L</given-names></name><name><surname>Morrone</surname><given-names>A</given-names></name><name><surname>Longhi</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant</article-title>. <source>J Infect</source> (<year>2007</year>) <volume>54</volume>:<fpage>e223</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jinf.2006.12.009</pub-id><?supplied-pmid 17307255?><pub-id pub-id-type="pmid">17307255</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Lin</surname><given-names>MC</given-names></name><name><surname>Hung</surname><given-names>CH</given-names></name></person-group>. <article-title>Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis</article-title>. <source>J Formos Med Assoc</source> (<year>2009</year>) <volume>108</volume>:<fpage>746</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/S0929-6646(09)60400-9</pub-id><?supplied-pmid 19773215?><pub-id pub-id-type="pmid">19773215</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkahla</surname><given-names>N</given-names></name><name><surname>Kchir</surname><given-names>H</given-names></name><name><surname>Maamouri</surname><given-names>N</given-names></name><name><surname>Ouerghi</surname><given-names>H</given-names></name><name><surname>Hariz</surname><given-names>FB</given-names></name><name><surname>Chouaib</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>[Reactivation of tuberculosis during dual therapy with pegylated interferon and ribavirin for chronic hepatitis C]</article-title>. <source>Rev Med Interne</source> (<year>2010</year>) <volume>31</volume>:<fpage>e1</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1016/j.revmed.2009.11.017</pub-id><?supplied-pmid 20605283?><pub-id pub-id-type="pmid">20605283</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babudieri</surname><given-names>S</given-names></name><name><surname>Soddu</surname><given-names>A</given-names></name><name><surname>Murino</surname><given-names>M</given-names></name><name><surname>Molicotti</surname><given-names>P</given-names></name><name><surname>Muredda</surname><given-names>AA</given-names></name><name><surname>Madeddu</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Tuberculosis screening before anti-hepatitis C virus therapy in prisons</article-title>. <source>Emerg Infect Dis</source> (<year>2012</year>) <volume>18</volume>:<fpage>689</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.3201/eid1804.111016</pub-id><pub-id pub-id-type="pmid">22469015</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardigni</surname><given-names>V</given-names></name><name><surname>Fabbri</surname><given-names>G</given-names></name><name><surname>Badia</surname><given-names>L</given-names></name><name><surname>Grilli</surname><given-names>A</given-names></name><name><surname>Contini</surname><given-names>C</given-names></name></person-group>
<article-title>Tuberculosis reactivation in a patient with chronic HBV infection undergoing PEG-interferon therapy: case report and literature review</article-title>. <source>J Infect Dis Ther</source> (<year>2013</year>) <volume>1</volume>:<fpage>3</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Fujikawa</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Ochiai</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Moriyama</surname><given-names>M</given-names></name></person-group>. <article-title>Onset of tuberculosis from a pulmonary latent tuberculosis infection during antiviral triple therapy for chronic hepatitis C</article-title>. <source>Intern Med</source> (<year>2016</year>) <volume>55</volume>:<fpage>2011</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2169/internalmedicine.55.6448</pub-id><?supplied-pmid 27477407?><pub-id pub-id-type="pmid">27477407</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Mcnab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title>. <source>Genes Immun</source> (<year>2011</year>) <volume>12</volume>:<fpage>15</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/gene.2010.51</pub-id><?supplied-pmid 20861863?><pub-id pub-id-type="pmid">20861863</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Dass</surname><given-names>RH</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>MM</given-names></name><name><surname>Wong</surname><given-names>HE</given-names></name><name><surname>Sahiratmadja</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e45839</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0045839</pub-id><?supplied-pmid 23029268?><pub-id pub-id-type="pmid">23029268</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cliff</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Constantinou</surname><given-names>N</given-names></name><name><surname>Cho</surname><given-names>JE</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Ronacher</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response</article-title>. <source>J Infect Dis</source> (<year>2013</year>) <volume>207</volume>:<fpage>18</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jis499</pub-id><?supplied-pmid 22872737?><pub-id pub-id-type="pmid">22872737</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Penn-Nicholson</surname><given-names>A</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Thompson</surname><given-names>E</given-names></name><name><surname>Suliman</surname><given-names>S</given-names></name><name><surname>Amon</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>387</volume>:<fpage>2312</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(15)01316-1</pub-id><?supplied-pmid 27017310?><pub-id pub-id-type="pmid">27017310</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e73230</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0073230</pub-id><?supplied-pmid 24066041?><pub-id pub-id-type="pmid">24066041</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Bergtold</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2001</year>) <volume>98</volume>:<fpage>5752</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><?supplied-pmid 11320211?><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>.&#x02009;<source>J Interferon Cytokine Res</source> (<year>2005</year>) <volume>25</volume>:<fpage>694</fpage>&#x02013;<lpage>701</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2005.25.694</pub-id><?supplied-pmid 16318583?><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordway</surname><given-names>D</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M</given-names></name><name><surname>Harton</surname><given-names>M</given-names></name><name><surname>Palanisamy</surname><given-names>G</given-names></name><name><surname>Troudt</surname><given-names>J</given-names></name><name><surname>Shanley</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The hypervirulent <italic>Mycobacterium tuberculosis</italic> strain HN878 induces a potent TH1 response followed by rapid down-regulation</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>522</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.1.522</pub-id><?supplied-pmid 17579073?><pub-id pub-id-type="pmid">17579073</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SA</given-names></name><name><surname>Johndrow</surname><given-names>JE</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group>. <article-title>The Type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>3143</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3143</pub-id><?supplied-pmid 17312162?><pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>. <article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>6205</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1200255</pub-id><?supplied-pmid 22566567?><pub-id pub-id-type="pmid">22566567</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>:<fpage>2380</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id><?supplied-pmid 24782112?><pub-id pub-id-type="pmid">24782112</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>JV</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group>. <article-title>Expression of the nitric oxide synthase 2 gene is not essential for early control of <italic>Mycobacterium tuberculosis</italic> in the murine lung</article-title>. <source>Infect Immun</source> (<year>2000</year>) <volume>68</volume>:<fpage>6879</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.68.12.6879-6882.2000</pub-id><?supplied-pmid 11083808?><pub-id pub-id-type="pmid">11083808</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Oland</surname><given-names>SD</given-names></name><name><surname>Amaral</surname><given-names>EP</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Gonzales</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source> (<year>2014</year>) <volume>511</volume>:<fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nature13489</pub-id><?supplied-pmid 24990750?><pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A</given-names></name><name><surname>Goncalves</surname><given-names>R</given-names></name><name><surname>Roffe</surname><given-names>E</given-names></name><name><surname>Cheever</surname><given-names>AW</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>:<fpage>1674</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1172/JCI40817</pub-id><?supplied-pmid 20389020?><pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Mcnab</surname><given-names>FW</given-names></name><name><surname>Stavropoulos</surname><given-names>E</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>:<fpage>270</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit424</pub-id><?supplied-pmid 23935205?><pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remoli</surname><given-names>ME</given-names></name><name><surname>Giacomini</surname><given-names>E</given-names></name><name><surname>Lutfalla</surname><given-names>G</given-names></name><name><surname>Dondi</surname><given-names>E</given-names></name><name><surname>Orefici</surname><given-names>G</given-names></name><name><surname>Battistini</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Selective expression of type I IFN genes in human dendritic cells infected with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>:<fpage>366</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.169.1.366</pub-id><?supplied-pmid 12077266?><pub-id pub-id-type="pmid">12077266</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariotti</surname><given-names>S</given-names></name><name><surname>Teloni</surname><given-names>R</given-names></name><name><surname>Iona</surname><given-names>E</given-names></name><name><surname>Fattorini</surname><given-names>L</given-names></name><name><surname>Romagnoli</surname><given-names>G</given-names></name><name><surname>Gagliardi</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>:<fpage>4385</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.72.8.4385-4392.2004</pub-id><?supplied-pmid 15271894?><pub-id pub-id-type="pmid">15271894</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienard</surname><given-names>J</given-names></name><name><surname>Movert</surname><given-names>E</given-names></name><name><surname>Valfridsson</surname><given-names>C</given-names></name><name><surname>Sturegard</surname><given-names>E</given-names></name><name><surname>Carlsson</surname><given-names>F</given-names></name></person-group>
<article-title>ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNgamma-mediated autophagy and growth restriction of intracellular mycobacteria</article-title>. <source>Cell Microbiol</source> (<year>2016</year>) <volume>18</volume>:<fpage>1471</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1111/cmi.12594</pub-id><pub-id pub-id-type="pmid">27062290</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name><name><surname>Coulombe</surname><given-names>F</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000500</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id><?supplied-pmid 19578435?><pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzanillo</surname><given-names>PS</given-names></name><name><surname>Shiloh</surname><given-names>MU</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic> activates the DNA-dependent cytosolic surveillance pathway within macrophages</article-title>. <source>Cell Host Microbe</source> (<year>2012</year>) <volume>11</volume>:<fpage>469</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2012.03.007</pub-id><?supplied-pmid 22607800?><pub-id pub-id-type="pmid">22607800</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>AC</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Nair</surname><given-names>VR</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP synthase is an innate immune DNA sensor for <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>:<fpage>820</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.005</pub-id><?supplied-pmid 26048137?><pub-id pub-id-type="pmid">26048137</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassermann</surname><given-names>R</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Perin</surname><given-names>SG</given-names></name><name><surname>Lou</surname><given-names>Y</given-names></name><name><surname>Rybniker</surname><given-names>J</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>:<fpage>799</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.003</pub-id><?supplied-pmid 26048138?><pub-id pub-id-type="pmid">26048138</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>RO</given-names></name><name><surname>Bell</surname><given-names>SL</given-names></name><name><surname>Macduff</surname><given-names>DA</given-names></name><name><surname>Kimmey</surname><given-names>JM</given-names></name><name><surname>Diner</surname><given-names>EJ</given-names></name><name><surname>Olivas</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The cytosolic sensor cGAS detects <italic>Mycobacterium tuberculosis</italic> DNA to induce type I interferons and activate autophagy</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>17</volume>:<fpage>811</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.004</pub-id><?supplied-pmid 26048136?><pub-id pub-id-type="pmid">26048136</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houben</surname><given-names>D</given-names></name><name><surname>Demangel</surname><given-names>C</given-names></name><name><surname>Van Ingen</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>J</given-names></name><name><surname>Baldeon</surname><given-names>L</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria</article-title>. <source>Cell Microbiol</source> (<year>2012</year>) <volume>14</volume>:<fpage>1287</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01799.x</pub-id><?supplied-pmid 22524898?><pub-id pub-id-type="pmid">22524898</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>B</given-names></name><name><surname>Dey</surname><given-names>RJ</given-names></name><name><surname>Cheung</surname><given-names>LS</given-names></name><name><surname>Pokkali</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>:<fpage>401</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3813</pub-id><?supplied-pmid 25730264?><pub-id pub-id-type="pmid">25730264</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiga</surname><given-names>H</given-names></name><name><surname>Kitada</surname><given-names>S</given-names></name><name><surname>Shimada</surname><given-names>Y</given-names></name><name><surname>Kamiyama</surname><given-names>N</given-names></name><name><surname>Okuyama</surname><given-names>M</given-names></name><name><surname>Makino</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Critical role of AIM2 in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Int Immunol</source> (<year>2012</year>) <volume>24</volume>:<fpage>637</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxs062</pub-id><?supplied-pmid 22695634?><pub-id pub-id-type="pmid">22695634</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>E</given-names></name><name><surname>Kawade</surname><given-names>Y</given-names></name><name><surname>Iwakura</surname><given-names>Y</given-names></name></person-group>. <article-title>Induction of interferon-alpha by interferon-beta, but not of interferon-beta by interferon-alpha, in the mouse</article-title>. <source>Virology</source> (<year>1990</year>) <volume>176</volume>:<fpage>30</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/0042-6822(90)90227-I</pub-id><?supplied-pmid 2330678?><pub-id pub-id-type="pmid">2330678</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiecki</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>The multifaceted biology of plasmacytoid dendritic cells</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>471</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1038/nri3865</pub-id><?supplied-pmid 26160613?><pub-id pub-id-type="pmid">26160613</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraav</surname><given-names>I</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group>. <article-title>Outcome of <italic>Mycobacterium tuberculosis</italic> and Toll-like receptor interaction: immune response or immune evasion?</article-title>
<source>Immunol Cell Biol</source> (<year>2014</year>) <volume>92</volume>:<fpage>741</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2014.52</pub-id><?supplied-pmid 24983458?><pub-id pub-id-type="pmid">24983458</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mvubu</surname><given-names>NE</given-names></name><name><surname>Pillay</surname><given-names>B</given-names></name><name><surname>Gamieldien</surname><given-names>J</given-names></name><name><surname>Bishai</surname><given-names>W</given-names></name><name><surname>Pillay</surname><given-names>M</given-names></name></person-group>. <article-title>Canonical pathways, networks and transcriptional factor regulation by clinical strains of <italic>Mycobacterium tuberculosis</italic> in pulmonary alveolar epithelial cells</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2016</year>) <volume>97</volume>:<fpage>73</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2015.12.002</pub-id><?supplied-pmid 26980499?><pub-id pub-id-type="pmid">26980499</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bafica</surname><given-names>A</given-names></name><name><surname>Scanga</surname><given-names>CA</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Leifer</surname><given-names>C</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group>. <article-title>TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>:<fpage>1715</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20051782</pub-id><?supplied-pmid 16365150?><pub-id pub-id-type="pmid">16365150</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>:<fpage>1023</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyadova</surname><given-names>IV</given-names></name><name><surname>Tsiganov</surname><given-names>EN</given-names></name><name><surname>Kapina</surname><given-names>MA</given-names></name><name><surname>Shepelkova</surname><given-names>GS</given-names></name><name><surname>Sosunov</surname><given-names>VV</given-names></name><name><surname>Radaeva</surname><given-names>TV</given-names></name><etal/></person-group>
<article-title>In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>5</volume>:<fpage>e10469</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0010469</pub-id><?supplied-pmid 20454613?><pub-id pub-id-type="pmid">20454613</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knaul</surname><given-names>JK</given-names></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Oberbeck-Mueller</surname><given-names>D</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><name><surname>Scheuermann</surname><given-names>L</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2014</year>) <volume>190</volume>:<fpage>1053</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201405-0828OC</pub-id><?supplied-pmid 25275852?><pub-id pub-id-type="pmid">25275852</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsiganov</surname><given-names>EN</given-names></name><name><surname>Verbina</surname><given-names>EM</given-names></name><name><surname>Radaeva</surname><given-names>TV</given-names></name><name><surname>Sosunov</surname><given-names>VV</given-names></name><name><surname>Kosmiadi</surname><given-names>GA</given-names></name><name><surname>Nikitina</surname><given-names>IY</given-names></name><etal/></person-group>
<article-title>Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>4718</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1301365</pub-id><?supplied-pmid 24711621?><pub-id pub-id-type="pmid">24711621</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleetwood</surname><given-names>AJ</given-names></name><name><surname>Dinh</surname><given-names>H</given-names></name><name><surname>Cook</surname><given-names>AD</given-names></name><name><surname>Hertzog</surname><given-names>PJ</given-names></name><name><surname>Hamilton</surname><given-names>JA</given-names></name></person-group>. <article-title>GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling</article-title>. <source>J Leukoc Biol</source> (<year>2009</year>) <volume>86</volume>:<fpage>411</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.1108702</pub-id><?supplied-pmid 19406830?><pub-id pub-id-type="pmid">19406830</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrady</surname><given-names>CD</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Mandal</surname><given-names>NA</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Carr</surname><given-names>DJ</given-names></name></person-group>
<article-title>IFN-alpha-driven CCL2 production recruits inflammatory monocytes to infection site in mice</article-title>. <source>Mucosal Immunol</source> (<year>2013</year>) <volume>6</volume>:<fpage>45</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2012.46</pub-id><pub-id pub-id-type="pmid">22692455</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Galligan</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Non-myeloid cells are major contributors to innate immune responses via production of monocyte chemoattractant protein-1/CCL2</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>4</volume>:<fpage>482</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2013.00482</pub-id><?supplied-pmid 24432017?><pub-id pub-id-type="pmid">24432017</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Sada-Ovalle</surname><given-names>I</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><etal/></person-group>
<article-title>IL-1beta promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>4196</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202688</pub-id><pub-id pub-id-type="pmid">23487424</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>NC</given-names></name><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>T</given-names></name><name><surname>Papayannopoulou</surname><given-names>T</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name><name><surname>Iwakura</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Interdependence between interleukin-1 and tumor necrosis factor regulates TNF-dependent control of <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>:<fpage>1125</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.11.016</pub-id><?supplied-pmid 26682985?><pub-id pub-id-type="pmid">26682985</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname><given-names>SM</given-names></name><name><surname>Martin</surname><given-names>CJ</given-names></name><name><surname>Booty</surname><given-names>MG</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Gan</surname><given-names>HX</given-names></name><etal/></person-group>
<article-title>Apoptosis is an innate defense function of macrophages against <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Mucosal Immunol</source> (<year>2011</year>) <volume>4</volume>:<fpage>279</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2011.3</pub-id><?supplied-pmid 21307848?><pub-id pub-id-type="pmid">21307848</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Chan</surname><given-names>LS</given-names></name><name><surname>Wong</surname><given-names>SF</given-names></name></person-group>. <article-title>The course of fever during treatment of pulmonary tuberculosis</article-title>. <source>Tubercle</source> (<year>1987</year>) <volume>68</volume>:<fpage>255</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/0041-3879(87)90065-1</pub-id><?supplied-pmid 3455566?><pub-id pub-id-type="pmid">3455566</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Coppari</surname><given-names>R</given-names></name><name><surname>Bass</surname><given-names>CE</given-names></name><name><surname>Mochizuki</surname><given-names>T</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><etal/></person-group>
<article-title>EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses</article-title>. <source>Nat Neurosci</source> (<year>2007</year>) <volume>10</volume>:<fpage>1131</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/nn1949</pub-id><?supplied-pmid 17676060?><pub-id pub-id-type="pmid">17676060</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname><given-names>B</given-names></name><name><surname>Yoon</surname><given-names>YS</given-names></name><name><surname>Le Lay</surname><given-names>J</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Hedrick</surname><given-names>S</given-names></name><name><surname>Montminy</surname><given-names>M</given-names></name></person-group>. <article-title>CREB pathway links PGE2 signaling with macrophage polarization</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2015</year>) <volume>112</volume>:<fpage>15642</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1519644112</pub-id><?supplied-pmid 26644581?><pub-id pub-id-type="pmid">26644581</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serezani</surname><given-names>CH</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Ballinger</surname><given-names>MN</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><name><surname>Aronoff</surname><given-names>DM</given-names></name><name><surname>Peters-Golden</surname><given-names>M</given-names></name></person-group>. <article-title>Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2007</year>) <volume>37</volume>:<fpage>562</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2007-0153OC</pub-id><?supplied-pmid 17585108?><pub-id pub-id-type="pmid">17585108</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>KF</given-names></name><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Naqvi</surname><given-names>S</given-names></name><name><surname>Mcguire</surname><given-names>VA</given-names></name><name><surname>Noehren</surname><given-names>G</given-names></name><name><surname>Kristariyanto</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>565</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202462</pub-id><?supplied-pmid 23241891?><pub-id pub-id-type="pmid">23241891</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Sarhan</surname><given-names>D</given-names></name><name><surname>Poschke</surname><given-names>I</given-names></name><name><surname>Lundqvist</surname><given-names>A</given-names></name><name><surname>Kiessling</surname><given-names>R</given-names></name></person-group>
<article-title>Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity</article-title>. <source>J Immunother Cancer</source> (<year>2014</year>) <volume>2</volume>:<fpage>224</fpage>&#x02013;<lpage>224</lpage>.<pub-id pub-id-type="doi">10.1186/2051-1426-2-S3-P224</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boniface</surname><given-names>K</given-names></name><name><surname>Bak-Jensen</surname><given-names>KS</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Blumenschein</surname><given-names>WM</given-names></name><name><surname>Mcgeachy</surname><given-names>MJ</given-names></name><name><surname>Mcclanahan</surname><given-names>TK</given-names></name><etal/></person-group>
<article-title>Prostaglandin E2 regulates Th17&#x02009;cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>535</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20082293</pub-id><?supplied-pmid 19273625?><pub-id pub-id-type="pmid">19273625</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>PGE2 elevates IL-23 production in human dendritic cells via a cAMP dependent pathway</article-title>. <source>Mediators Inflamm</source> (<year>2015</year>) <volume>2015</volume>:<fpage>984690</fpage>.<pub-id pub-id-type="doi">10.1155/2015/984690</pub-id><?supplied-pmid 26412948?><pub-id pub-id-type="pmid">26412948</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminskaia</surname><given-names>GO</given-names></name><name><surname>Blonskaia</surname><given-names>G</given-names></name><name><surname>Omarov</surname><given-names>TO</given-names></name><name><surname>Lovacheva</surname><given-names>OV</given-names></name></person-group>
<article-title>[Level and ratio of prostaglandins group E and F2(alpha) in bronchoalveolar washes in pulmonary tuberculosis patients] Soderzhanie i sootnosheniia prostaglandinov grupp E i F2(alpha) v bronkhoal&#x02019;veoliarnykh smyvakh u bol&#x02019;nykh tuberkulezom legkikh</article-title>. <source>Vopr Med Khim</source> (<year>1991</year>) <volume>37</volume>:<fpage>71</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>CC</given-names></name><name><surname>Wu</surname><given-names>MF</given-names></name><name><surname>Hsu</surname><given-names>CL</given-names></name><name><surname>Huang</surname><given-names>CT</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Hsieh</surname><given-names>SL</given-names></name><etal/></person-group>
<article-title>Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction</article-title>. <source>BMC Infect Dis</source> (<year>2013</year>) <volume>13</volume>:<fpage>45</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-13-45</pub-id><?supplied-pmid 23356448?><pub-id pub-id-type="pmid">23356448</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>LL</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>YL</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Polymorphisms in the prostaglandin receptor EP2 gene confers susceptibility to tuberculosis</article-title>. <source>Infect Genet Evol</source> (<year>2016</year>) <volume>46</volume>:<fpage>23</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.meegid.2016.10.016</pub-id><?supplied-pmid 27780787?><pub-id pub-id-type="pmid">27780787</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel Moreno</surname><given-names>J</given-names></name><name><surname>Estrada Garcia</surname><given-names>I</given-names></name><name><surname>De La Luz Garcia Hernandez</surname><given-names>M</given-names></name><name><surname>Aguilar Leon</surname><given-names>D</given-names></name><name><surname>Marquez</surname><given-names>R</given-names></name><name><surname>Hernandez Pando</surname><given-names>R</given-names></name></person-group>. <article-title>The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis</article-title>. <source>Immunology</source> (<year>2002</year>) <volume>106</volume>:<fpage>257</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2567.2002.01403.x</pub-id><?supplied-pmid 12047755?><pub-id pub-id-type="pmid">12047755</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalinski</surname><given-names>P</given-names></name></person-group>. <article-title>Regulation of immune responses by prostaglandin E2</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>21</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1101029</pub-id><?supplied-pmid 22187483?><pub-id pub-id-type="pmid">22187483</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Allain</surname><given-names>S</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name></person-group>
<article-title>Foamy macrophages and the progression of the human tuberculosis granuloma</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>:<fpage>943</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1781</pub-id><pub-id pub-id-type="pmid">19692995</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A</given-names></name><name><surname>Cardone</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Kirschman</surname><given-names>KD</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>2540</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1100926</pub-id><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Ewbank</surname><given-names>J</given-names></name><name><surname>Howes</surname><given-names>A</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Martirosyan</surname><given-names>A</given-names></name><name><surname>Ghilardi</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic>-infected macrophages</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>3600</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401088</pub-id><pub-id pub-id-type="pmid">25187652</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Gan</surname><given-names>H</given-names></name><name><surname>Shin</surname><given-names>DS</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>DM</given-names></name><etal/></person-group>
<article-title>Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death</article-title>. <source>J Exp Med</source> (<year>2008</year>) <volume>205</volume>:<fpage>2791</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20080767</pub-id><?supplied-pmid 18955568?><pub-id pub-id-type="pmid">18955568</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>AM</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group>. <article-title>IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>4662</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.7.4662</pub-id><?supplied-pmid 16982905?><pub-id pub-id-type="pmid">16982905</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Behi</surname><given-names>M</given-names></name><name><surname>Ciric</surname><given-names>B</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Cullimore</surname><given-names>M</given-names></name><name><surname>Safavi</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>:<fpage>568</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2031</pub-id><?supplied-pmid 21516111?><pub-id pub-id-type="pmid">21516111</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremond</surname><given-names>CM</given-names></name><name><surname>Togbe</surname><given-names>D</given-names></name><name><surname>Doz</surname><given-names>E</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Vasseur</surname><given-names>V</given-names></name><name><surname>Maillet</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>1178</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1178</pub-id><?supplied-pmid 17617611?><pub-id pub-id-type="pmid">17617611</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Rathinam</surname><given-names>VA</given-names></name><name><surname>Martens</surname><given-names>GW</given-names></name><name><surname>Martinot</surname><given-names>AJ</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><etal/></person-group>
<article-title>Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>52</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2474</pub-id><pub-id pub-id-type="pmid">23160153</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Une</surname><given-names>C</given-names></name><name><surname>Andersson</surname><given-names>J</given-names></name><name><surname>Orn</surname><given-names>A</given-names></name></person-group>. <article-title>Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with <italic>Trypanosoma cruzi</italic></article-title>. <source>Clin Exp Immunol</source> (<year>2003</year>) <volume>134</volume>:<fpage>195</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02294.x</pub-id><?supplied-pmid 14616777?><pub-id pub-id-type="pmid">14616777</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhi</surname><given-names>MP</given-names></name><name><surname>Trumpfheller</surname><given-names>C</given-names></name><name><surname>Idoyaga</surname><given-names>J</given-names></name><name><surname>Caskey</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>I</given-names></name><name><surname>Kluger</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>1589</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20090247</pub-id><?supplied-pmid 19564349?><pub-id pub-id-type="pmid">19564349</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Allele-specific induction of IL-1beta expression by C/EBPbeta and PU.1 contributes to increased tuberculosis susceptibility</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1004426</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004426</pub-id><pub-id pub-id-type="pmid">25329476</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berclaz</surname><given-names>PY</given-names></name><name><surname>Carey</surname><given-names>B</given-names></name><name><surname>Fillipi</surname><given-names>MD</given-names></name><name><surname>Wernke-Dollries</surname><given-names>K</given-names></name><name><surname>Geraci</surname><given-names>N</given-names></name><name><surname>Cush</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2007</year>) <volume>36</volume>:<fpage>114</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2006-0174OC</pub-id><?supplied-pmid 16917076?><pub-id pub-id-type="pmid">16917076</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>DM</given-names></name><name><surname>Sanchez-Campillo</surname><given-names>J</given-names></name><name><surname>Rosas-Taraco</surname><given-names>AG</given-names></name><name><surname>Higgins</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name><etal/></person-group>
<article-title>Relative levels of M-CSF and GM-CSF influence the specific generation of macrophage populations during infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<fpage>4892</fpage>&#x02013;<lpage>900</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.180.7.4892</pub-id><?supplied-pmid 18354213?><pub-id pub-id-type="pmid">18354213</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fejer</surname><given-names>G</given-names></name><name><surname>Wegner</surname><given-names>MD</given-names></name><name><surname>Gyory</surname><given-names>I</given-names></name><name><surname>Cohen</surname><given-names>I</given-names></name><name><surname>Engelhard</surname><given-names>P</given-names></name><name><surname>Voronov</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2013</year>) <volume>110</volume>:<fpage>E2191</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1302877110</pub-id><?supplied-pmid 23708119?><pub-id pub-id-type="pmid">23708119</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nandi</surname><given-names>B</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group>
<article-title>Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<fpage>2251</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20110919</pub-id><pub-id pub-id-type="pmid">21967766</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bruin</surname><given-names>AM</given-names></name><name><surname>Voermans</surname><given-names>C</given-names></name><name><surname>Nolte</surname><given-names>MA</given-names></name></person-group>
<article-title>Impact of interferon-gamma on hematopoiesis</article-title>. <source>Blood</source> (<year>2014</year>) <volume>124</volume>:<fpage>2479</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-04-568451</pub-id><pub-id pub-id-type="pmid">25185711</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reboldi</surname><given-names>A</given-names></name><name><surname>Dang</surname><given-names>EV</given-names></name><name><surname>Mcdonald</surname><given-names>JG</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>Inflammation. 25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon</article-title>. <source>Science</source> (<year>2014</year>) <volume>345</volume>:<fpage>679</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1126/science.1254790</pub-id><?supplied-pmid 25104388?><pub-id pub-id-type="pmid">25104388</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeksema</surname><given-names>MA</given-names></name><name><surname>Scicluna</surname><given-names>BP</given-names></name><name><surname>Boshuizen</surname><given-names>MC</given-names></name><name><surname>Van Der Velden</surname><given-names>S</given-names></name><name><surname>Neele</surname><given-names>AE</given-names></name><name><surname>Van Den Bossche</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>IFN-gamma priming of macrophages represses a part of the inflammatory program and attenuates neutrophil recruitment</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>3909</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402077</pub-id><pub-id pub-id-type="pmid">25750432</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifter</surname><given-names>SA</given-names></name><name><surname>Bhattacharyya</surname><given-names>N</given-names></name><name><surname>Pillay</surname><given-names>R</given-names></name><name><surname>Florido</surname><given-names>M</given-names></name><name><surname>Triccas</surname><given-names>JA</given-names></name><name><surname>Britton</surname><given-names>WJ</given-names></name><etal/></person-group>
<article-title>Functional interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005378</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005378</pub-id><?supplied-pmid 26731100?><pub-id pub-id-type="pmid">26731100</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Staehli</surname><given-names>F</given-names></name><name><surname>Tardivel</surname><given-names>A</given-names></name><name><surname>Mattmann</surname><given-names>C</given-names></name><name><surname>Forster</surname><given-names>I</given-names></name><etal/></person-group>&#x02009;<article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>213</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id><?supplied-pmid 21349431?><pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourik</surname><given-names>BC</given-names></name><name><surname>Leenen</surname><given-names>PJ</given-names></name><name><surname>De Knegt</surname><given-names>GJ</given-names></name><name><surname>Huizinga</surname><given-names>R</given-names></name><name><surname>Van Der Eerden</surname><given-names>BC</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Immunotherapy added to antibiotic treatment reduces relapse of disease in a mouse model of tuberculosis</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2017</year>) <volume>56</volume>:<fpage>233</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2016-0185OC</pub-id><?supplied-pmid 27654457?><pub-id pub-id-type="pmid">27654457</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>G</given-names></name><name><surname>Humbert</surname><given-names>M</given-names></name><name><surname>Deauvieau</surname><given-names>F</given-names></name><name><surname>Scuiller</surname><given-names>M</given-names></name><name><surname>Hiscott</surname><given-names>J</given-names></name><name><surname>Bates</surname><given-names>EE</given-names></name><etal/></person-group>
<article-title>A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>:<fpage>1435</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20041964</pub-id><?supplied-pmid 15851485?><pub-id pub-id-type="pmid">15851485</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goriely</surname><given-names>S</given-names></name><name><surname>Molle</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Albarani</surname><given-names>V</given-names></name><name><surname>Haddou</surname><given-names>NO</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>1078</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-06-2416</pub-id><?supplied-pmid 16219795?><pub-id pub-id-type="pmid">16219795</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>J</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group>. <article-title>Regulation of antiviral T cell responses by type I interferons</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>231</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1038/nri3806</pub-id><?supplied-pmid 25790790?><pub-id pub-id-type="pmid">25790790</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spits</surname><given-names>H</given-names></name><name><surname>Bernink</surname><given-names>JH</given-names></name><name><surname>Lanier</surname><given-names>L</given-names></name></person-group>. <article-title>NK cells and type 1 innate lymphoid cells: partners in host defense</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>758</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3482</pub-id><?supplied-pmid 27328005?><pub-id pub-id-type="pmid">27328005</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name><name><surname>Malmgaard</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>C</given-names></name><name><surname>Asselin-Paturel</surname><given-names>C</given-names></name><name><surname>Briere</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>195</volume>:<fpage>517</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20011672</pub-id><?supplied-pmid 11854364?><pub-id pub-id-type="pmid">11854364</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>T</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Heitmann</surname><given-names>L</given-names></name><name><surname>Rausch</surname><given-names>A</given-names></name><name><surname>Mages</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>:<fpage>1301</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0803567</pub-id><?supplied-pmid 19561100?><pub-id pub-id-type="pmid">19561100</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Paus</surname><given-names>RA</given-names></name><name><surname>Van Wengen</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Verdegaal</surname><given-names>EM</given-names></name><name><surname>Van Dissel</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Inhibition of the type I immune responses of human monocytes by IFN-alpha and IFN-beta</article-title>. <source>Cytokine</source> (<year>2013</year>) <volume>61</volume>:<fpage>645</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2012.12.005</pub-id><pub-id pub-id-type="pmid">23299081</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>1448</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><?supplied-pmid 23449998?><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Obermajer</surname><given-names>N</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Nuthalapati</surname><given-names>N</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IL-23-dependent IL-17 drives Th1-cell responses following <italic>Mycobacterium bovis</italic> BCG vaccination</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>364</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201141569</pub-id><?supplied-pmid 22101830?><pub-id pub-id-type="pmid">22101830</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>H</given-names></name><name><surname>Aiba</surname><given-names>S</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Ohteki</surname><given-names>T</given-names></name><name><surname>Takada</surname><given-names>H</given-names></name></person-group>. <article-title>Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells</article-title>. <source>Infect Immun</source> (<year>2005</year>) <volume>73</volume>:<fpage>7967</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.73.12.7967-7976.2005</pub-id><?supplied-pmid 16299289?><pub-id pub-id-type="pmid">16299289</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manni</surname><given-names>M</given-names></name><name><surname>Granstein</surname><given-names>RD</given-names></name><name><surname>Maestroni</surname><given-names>G</given-names></name></person-group>
<article-title>beta2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response</article-title>. <source>Cytokine</source> (<year>2011</year>) <volume>55</volume>:<fpage>380</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2011.05.013</pub-id><pub-id pub-id-type="pmid">21683614</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AD</given-names></name><name><surname>Manickasingham</surname><given-names>SP</given-names></name><name><surname>Sporri</surname><given-names>R</given-names></name><name><surname>Diebold</surname><given-names>SS</given-names></name><name><surname>Schulz</surname><given-names>O</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>:<fpage>3652</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.169.7.3652</pub-id><?supplied-pmid 12244157?><pub-id pub-id-type="pmid">12244157</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napolitani</surname><given-names>G</given-names></name><name><surname>Rinaldi</surname><given-names>A</given-names></name><name><surname>Bertoni</surname><given-names>F</given-names></name><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>. <article-title>Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>:<fpage>769</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1038/ni1223</pub-id><?supplied-pmid 15995707?><pub-id pub-id-type="pmid">15995707</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Mcgovern</surname><given-names>N</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>Zelante</surname><given-names>T</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>970</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.011</pub-id><?supplied-pmid 23706669?><pub-id pub-id-type="pmid">23706669</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goriely</surname><given-names>S</given-names></name><name><surname>Neurath</surname><given-names>MF</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name></person-group>. <article-title>How microorganisms tip the balance between interleukin-12 family members</article-title>. <source>Nat Rev Immunol</source> (<year>2008</year>) <volume>8</volume>:<fpage>81</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nri2225</pub-id><?supplied-pmid 18084185?><pub-id pub-id-type="pmid">18084185</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Scheidt</surname><given-names>B</given-names></name><name><surname>Leung</surname><given-names>PS</given-names></name><name><surname>Yong</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Towne</surname><given-names>JE</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Combined anti-CD40 and anti-IL-23 monoclonal antibody therapy effectively suppresses tumor growth and metastases</article-title>. <source>Cancer Res</source> (<year>2014</year>) <volume>74</volume>:<fpage>2412</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1646</pub-id><?supplied-pmid 24556719?><pub-id pub-id-type="pmid">24556719</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochrein</surname><given-names>H</given-names></name><name><surname>O&#x02019;keeffe</surname><given-names>M</given-names></name><name><surname>Luft</surname><given-names>T</given-names></name><name><surname>Vandenabeele</surname><given-names>S</given-names></name><name><surname>Grumont</surname><given-names>RJ</given-names></name><name><surname>Maraskovsky</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>192</volume>:<fpage>823</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1084/jem.192.6.823</pub-id><?supplied-pmid 10993913?><pub-id pub-id-type="pmid">10993913</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guenova</surname><given-names>E</given-names></name><name><surname>Skabytska</surname><given-names>Y</given-names></name><name><surname>Hoetzenecker</surname><given-names>W</given-names></name><name><surname>Weindl</surname><given-names>G</given-names></name><name><surname>Sauer</surname><given-names>K</given-names></name><name><surname>Tham</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2015</year>) <volume>112</volume>:<fpage>2163</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1416922112</pub-id><?supplied-pmid 25646481?><pub-id pub-id-type="pmid">25646481</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyakh</surname><given-names>L</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Provezza</surname><given-names>L</given-names></name><name><surname>Carra</surname><given-names>G</given-names></name><name><surname>Gerosa</surname><given-names>F</given-names></name></person-group>. <article-title>Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans</article-title>. <source>Immunol Rev</source> (<year>2008</year>) <volume>226</volume>:<fpage>112</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00700.x</pub-id><?supplied-pmid 19161420?><pub-id pub-id-type="pmid">19161420</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roses</surname><given-names>RE</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Koldovsky</surname><given-names>U</given-names></name><name><surname>Koski</surname><given-names>G</given-names></name><name><surname>Czerniecki</surname><given-names>BJ</given-names></name></person-group>. <article-title>Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>5120</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.7.5120</pub-id><?supplied-pmid 18802116?><pub-id pub-id-type="pmid">18802116</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Askenase</surname><given-names>MH</given-names></name><name><surname>Han</surname><given-names>SJ</given-names></name><name><surname>Byrd</surname><given-names>AL</given-names></name><name><surname>Morais Da Fonseca</surname><given-names>D</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Wilhelm</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Bone-marrow-resident NK cells prime monocytes for regulatory function during infection</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>1130</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.05.011</pub-id><?supplied-pmid 26070484?><pub-id pub-id-type="pmid">26070484</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorgi</surname><given-names>CA</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Court</surname><given-names>N</given-names></name><name><surname>Carlos</surname><given-names>D</given-names></name><name><surname>Paula-Silva</surname><given-names>FW</given-names></name><name><surname>Assis</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e40523</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0040523</pub-id><?supplied-pmid 22808181?><pub-id pub-id-type="pmid">22808181</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra-Filardi</surname><given-names>E</given-names></name><name><surname>Nieto</surname><given-names>C</given-names></name><name><surname>Dominguez-Soto</surname><given-names>A</given-names></name><name><surname>Barroso</surname><given-names>R</given-names></name><name><surname>Sanchez-Mateos</surname><given-names>P</given-names></name><name><surname>Puig-Kroger</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>3858</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1302821</pub-id><?supplied-pmid 24639350?><pub-id pub-id-type="pmid">24639350</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langrish</surname><given-names>CL</given-names></name><name><surname>Mckenzie</surname><given-names>BS</given-names></name><name><surname>Wilson</surname><given-names>NJ</given-names></name><name><surname>De Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Kastelein</surname><given-names>RA</given-names></name><name><surname>Cua</surname><given-names>DJ</given-names></name></person-group>. <article-title>IL-12 and IL-23: master regulators of innate and adaptive immunity</article-title>. <source>Immunol Rev</source> (<year>2004</year>) <volume>202</volume>:<fpage>96</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00214.x</pub-id><?supplied-pmid 15546388?><pub-id pub-id-type="pmid">15546388</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Gilmartin</surname><given-names>L</given-names></name><name><surname>Bell</surname><given-names>GK</given-names></name><name><surname>Jelley-Gibbs</surname><given-names>DM</given-names></name><etal/></person-group>
<article-title>IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>175</volume>:<fpage>788</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.175.2.788</pub-id><?supplied-pmid 16002675?><pub-id pub-id-type="pmid">16002675</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Bettelli</surname><given-names>E</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group>. <article-title>IL-17 and Th17&#x02009;cells</article-title>. <source>Annu Rev Immunol</source> (<year>2009</year>) <volume>27</volume>:<fpage>485</fpage>&#x02013;<lpage>517</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132710</pub-id><?supplied-pmid 19132915?><pub-id pub-id-type="pmid">19132915</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubberts</surname><given-names>E</given-names></name></person-group>. <article-title>The IL-23-IL-17 axis in inflammatory arthritis</article-title>. <source>Nat Rev Rheumatol</source> (<year>2015</year>) <volume>11</volume>:<fpage>415</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2015.53</pub-id><?supplied-pmid 25907700?><pub-id pub-id-type="pmid">25907700</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>EE</given-names></name><name><surname>Mckenzie</surname><given-names>DR</given-names></name><name><surname>Bastow</surname><given-names>CR</given-names></name><name><surname>Gregor</surname><given-names>CE</given-names></name><name><surname>Fenix</surname><given-names>KA</given-names></name><name><surname>Ogunniyi</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17&#x02009;cells</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>8644</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms9644</pub-id><?supplied-pmid 26511769?><pub-id pub-id-type="pmid">26511769</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagliani</surname><given-names>N</given-names></name><name><surname>Amezcua Vesely</surname><given-names>MC</given-names></name><name><surname>Iseppon</surname><given-names>A</given-names></name><name><surname>Brockmann</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Palm</surname><given-names>NW</given-names></name><etal/></person-group>
<article-title>Th17&#x02009;cells transdifferentiate into regulatory T cells during resolution of inflammation</article-title>. <source>Nature</source> (<year>2015</year>) <volume>523</volume>:<fpage>221</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature14452</pub-id><?supplied-pmid 25924064?><pub-id pub-id-type="pmid">25924064</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>CE</given-names></name><name><surname>Lalor</surname><given-names>SJ</given-names></name><name><surname>Sweeney</surname><given-names>CM</given-names></name><name><surname>Brereton</surname><given-names>CF</given-names></name><name><surname>Lavelle</surname><given-names>EC</given-names></name><name><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>:<fpage>331</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.001</pub-id><?supplied-pmid 19682929?><pub-id pub-id-type="pmid">19682929</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>GK</given-names></name><name><surname>Newton</surname><given-names>G</given-names></name><name><surname>Tarrio</surname><given-names>ML</given-names></name><name><surname>Bu</surname><given-names>DX</given-names></name><name><surname>Maganto-Garcia</surname><given-names>E</given-names></name><name><surname>Azcutia</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>6287</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1200385</pub-id><pub-id pub-id-type="pmid">22566565</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>JA</given-names></name><name><surname>Hueber</surname><given-names>AJ</given-names></name><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Galm</surname><given-names>M</given-names></name><name><surname>Baum</surname><given-names>W</given-names></name><name><surname>Kitson</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Combined inhibition of tumor necrosis factor alpha and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody</article-title>. <source>Arthritis Rheumatol</source> (<year>2015</year>) <volume>67</volume>:<fpage>51</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1002/art.38896</pub-id><pub-id pub-id-type="pmid">25303306</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>. <article-title>IL-17 and Th17&#x02009;cells in tuberculosis</article-title>. <source>Cytokine Growth Factor Rev</source> (<year>2010</year>) <volume>21</volume>:<fpage>455</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.cytogfr.2010.10.004</pub-id><?supplied-pmid 21075039?><pub-id pub-id-type="pmid">21075039</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>R</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name></person-group>. <article-title>The IL-17F sequence variant is associated with susceptibility to tuberculosis</article-title>. <source>Gene</source> (<year>2013</year>) <volume>515</volume>:<fpage>229</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.gene.2012.11.017</pub-id><?supplied-pmid 23219503?><pub-id pub-id-type="pmid">23219503</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group>. <article-title>StIL-17 gene polymorphisms in the development of pulmonary tuberculosis</article-title>. <source>Int J Clin Exp Pathol</source> (<year>2015</year>) <volume>8</volume>:<fpage>3225</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 26045845?><pub-id pub-id-type="pmid">26045845</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milano</surname><given-names>M</given-names></name><name><surname>Moraes</surname><given-names>MO</given-names></name><name><surname>Rodenbusch</surname><given-names>R</given-names></name><name><surname>Carvalho</surname><given-names>CX</given-names></name><name><surname>Delcroix</surname><given-names>M</given-names></name><name><surname>Mousquer</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Single nucleotide polymorphisms in IL17A and IL6 are associated with decreased risk for pulmonary tuberculosis in Southern Brazilian population</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0147814</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0147814</pub-id><?supplied-pmid 26840977?><pub-id pub-id-type="pmid">26840977</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>28586</fpage>.<pub-id pub-id-type="doi">10.1038/srep28586</pub-id><?supplied-pmid 27339100?><pub-id pub-id-type="pmid">27339100</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abhimanyu</surname></name><name><surname>Bose</surname><given-names>M</given-names></name><name><surname>Komal</surname></name><name><surname>Varma-Basil</surname><given-names>M</given-names></name></person-group>
<article-title>Lack of association between IL17A and IL17F polymorphisms and related serum levels in north Indians with tuberculosis</article-title>. <source>Gene</source> (<year>2013</year>) <volume>529</volume>:<fpage>195</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.gene.2013.06.090</pub-id><pub-id pub-id-type="pmid">23876429</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulat-Kardum</surname><given-names>LJ</given-names></name><name><surname>Etokebe</surname><given-names>GE</given-names></name><name><surname>Lederer</surname><given-names>P</given-names></name><name><surname>Balen</surname><given-names>S</given-names></name><name><surname>Dembic</surname><given-names>Z</given-names></name></person-group>. <article-title>Genetic polymorphisms in the toll-like receptor 10, interleukin (IL)17A and IL17F genes differently affect the risk for tuberculosis in croatian population</article-title>. <source>Scand J Immunol</source> (<year>2015</year>) <volume>82</volume>:<fpage>63</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/sji.12300</pub-id><?supplied-pmid 25857634?><pub-id pub-id-type="pmid">25857634</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Graner</surname><given-names>MW</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2010</year>) <volume>181</volume>:<fpage>734</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200909-1463OC</pub-id><?supplied-pmid 20019339?><pub-id pub-id-type="pmid">20019339</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>J</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Filion</surname><given-names>LG</given-names></name><name><surname>Angel</surname><given-names>JB</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Cameron</surname><given-names>DW</given-names></name></person-group>
<article-title>Comparison of interferon-gamma-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection</article-title>. <source>Clin Exp Immunol</source> (<year>2012</year>) <volume>167</volume>:<fpage>317</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2011.04520.x</pub-id><pub-id pub-id-type="pmid">22236009</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Kalsdorf</surname><given-names>B</given-names></name><name><surname>Abrahams</surname><given-names>DA</given-names></name><name><surname>Isaacs</surname><given-names>F</given-names></name><name><surname>Hofmeister</surname><given-names>J</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<fpage>1962</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.180.3.1962</pub-id><?supplied-pmid 18209095?><pub-id pub-id-type="pmid">18209095</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalfe</surname><given-names>JZ</given-names></name><name><surname>Everett</surname><given-names>CK</given-names></name><name><surname>Steingart</surname><given-names>KR</given-names></name><name><surname>Cattamanchi</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Hopewell</surname><given-names>PC</given-names></name><etal/></person-group>
<article-title>Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis</article-title>. <source>J Infect Dis</source> (<year>2011</year>) <volume>204</volume>(<issue>Suppl 4</issue>):<fpage>S1120</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jir410</pub-id><pub-id pub-id-type="pmid">21996694</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Denkinger</surname><given-names>CM</given-names></name><name><surname>Kik</surname><given-names>SV</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Zwerling</surname><given-names>A</given-names></name><name><surname>Oxlade</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Gamma interferon release assays for detection of <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Clin Microbiol Rev</source> (<year>2014</year>) <volume>27</volume>:<fpage>3</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.00034-13</pub-id><?supplied-pmid 24396134?><pub-id pub-id-type="pmid">24396134</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Beyers</surname><given-names>N</given-names></name><name><surname>Aguirre</surname><given-names>A</given-names></name><name><surname>Walzl</surname><given-names>G</given-names></name></person-group>. <article-title>Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels</article-title>. <source>J Infect Dis</source> (<year>2007</year>) <volume>195</volume>:<fpage>870</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1086/511277</pub-id><?supplied-pmid 17299718?><pub-id pub-id-type="pmid">17299718</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Dey</surname><given-names>AB</given-names></name><name><surname>Mitra</surname><given-names>DK</given-names></name></person-group>
<article-title>Inhibiting the programmed death 1 pathway rescues <italic>Mycobacterium tuberculosis</italic>-specific interferon gamma-producing T cells from apoptosis in patients with pulmonary tuberculosis</article-title>. <source>J Infect Dis</source> (<year>2013</year>) <volume>208</volume>:<fpage>603</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit206</pub-id><pub-id pub-id-type="pmid">23661793</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashenafi</surname><given-names>S</given-names></name><name><surname>Aderaye</surname><given-names>G</given-names></name><name><surname>Bekele</surname><given-names>A</given-names></name><name><surname>Zewdie</surname><given-names>M</given-names></name><name><surname>Aseffa</surname><given-names>G</given-names></name><name><surname>Hoang</surname><given-names>AT</given-names></name><etal/></person-group>
<article-title>Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3</article-title>. <source>Clin Immunol</source> (<year>2014</year>) <volume>151</volume>:<fpage>84</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/j.clim.2014.01.010</pub-id><?supplied-pmid 24584041?><pub-id pub-id-type="pmid">24584041</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname><given-names>MC</given-names></name><name><surname>Van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Goletti</surname><given-names>D</given-names></name><name><surname>Vanini</surname><given-names>V</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><etal/></person-group>
<article-title>KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2016</year>) <volume>97</volume>:<fpage>163</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2015.11.008</pub-id><?supplied-pmid 26750180?><pub-id pub-id-type="pmid">26750180</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandaru</surname><given-names>A</given-names></name><name><surname>Devalraju</surname><given-names>KP</given-names></name><name><surname>Paidipally</surname><given-names>P</given-names></name><name><surname>Dhiman</surname><given-names>R</given-names></name><name><surname>Venkatasubramanian</surname><given-names>S</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name><etal/></person-group>
<article-title>Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>:<fpage>2013</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343680</pub-id><?supplied-pmid 24643836?><pub-id pub-id-type="pmid">24643836</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>JI</given-names></name><name><surname>Geffner</surname><given-names>LJ</given-names></name><name><surname>Romero</surname><given-names>MM</given-names></name><name><surname>Balboa</surname><given-names>L</given-names></name><name><surname>Sabio</surname><given-names>YGC</given-names></name><name><surname>Ritacco</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Outbreaks of <italic>Mycobacterium tuberculosis</italic> MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load</article-title>. <source>J Infect Dis</source> (<year>2011</year>) <volume>204</volume>:<fpage>1054</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jir460</pub-id><?supplied-pmid 21881121?><pub-id pub-id-type="pmid">21881121</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>ND</given-names></name><name><surname>Paris</surname><given-names>SC</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>LF</given-names></name></person-group>. <article-title>Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis</article-title>. <source>Clin Vaccine Immunol</source> (<year>2012</year>) <volume>19</volume>:<fpage>1667</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00390-12</pub-id><?supplied-pmid 22914361?><pub-id pub-id-type="pmid">22914361</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>ND</given-names></name><name><surname>Paris</surname><given-names>SC</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>LF</given-names></name></person-group>. <article-title>Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2013</year>) <volume>93</volume>:<fpage>155</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2012.12.002</pub-id><?supplied-pmid 23332142?><pub-id pub-id-type="pmid">23332142</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreau</surname><given-names>M</given-names></name><name><surname>Rozot</surname><given-names>V</given-names></name><name><surname>Welles</surname><given-names>HC</given-names></name><name><surname>Belluti-Enders</surname><given-names>F</given-names></name><name><surname>Vigano</surname><given-names>S</given-names></name><name><surname>Maillard</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Lack of <italic>Mycobacterium tuberculosis</italic>-specific interleukin-17A-producing CD4+ T cells in active disease</article-title>. <source>Eur J Immunol</source> (<year>2013</year>) <volume>43</volume>:<fpage>939</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201243090</pub-id><?supplied-pmid 23436562?><pub-id pub-id-type="pmid">23436562</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurado</surname><given-names>JO</given-names></name><name><surname>Pasquinelli</surname><given-names>V</given-names></name><name><surname>Alvarez</surname><given-names>IB</given-names></name><name><surname>Pena</surname><given-names>D</given-names></name><name><surname>Rovetta</surname><given-names>AI</given-names></name><name><surname>Tateosian</surname><given-names>NL</given-names></name><etal/></person-group>
<article-title>IL-17 and IFN-gamma expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease</article-title>. <source>J Leukoc Biol</source> (<year>2012</year>) <volume>91</volume>:<fpage>991</fpage>&#x02013;<lpage>1002</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.1211619</pub-id><pub-id pub-id-type="pmid">22416258</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidarnezhad</surname><given-names>F</given-names></name><name><surname>Asnaashari</surname><given-names>A</given-names></name><name><surname>Rezaee</surname><given-names>SA</given-names></name><name><surname>Ghezelsofla</surname><given-names>R</given-names></name><name><surname>Ghazvini</surname><given-names>K</given-names></name><name><surname>Valizadeh</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Evaluation of Interleukin 17 and Interleukin 23 expression in patients with active and latent tuberculosis infection</article-title>. <source>Iran J Basic Med Sci</source> (<year>2016</year>) <volume>19</volume>:<fpage>844</fpage>&#x02013;<lpage>50</lpage>.<?supplied-pmid 27746865?><pub-id pub-id-type="pmid">27746865</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>G</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10</article-title>. <source>J Transl Med</source> (<year>2016</year>) <volume>14</volume>:<fpage>179</fpage><pub-id pub-id-type="doi">10.1186/s12967-016-0909-6</pub-id><pub-id pub-id-type="pmid">27311307</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sargentini</surname><given-names>V</given-names></name><name><surname>Mariotti</surname><given-names>S</given-names></name><name><surname>Carrara</surname><given-names>S</given-names></name><name><surname>Gagliardi</surname><given-names>MC</given-names></name><name><surname>Teloni</surname><given-names>R</given-names></name><name><surname>Goletti</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis</article-title>. <source>BMC Infect Dis</source> (<year>2009</year>) <volume>9</volume>:<fpage>99</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-9-99</pub-id><?supplied-pmid 19549330?><pub-id pub-id-type="pmid">19549330</pub-id></mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><etal/></person-group>
<article-title>The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7</article-title>. <source>Scand J Immunol</source> (<year>2012</year>) <volume>76</volume>:<fpage>580</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3083.2012.02776.x</pub-id><pub-id pub-id-type="pmid">22946827</pub-id></mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>NP</given-names></name><name><surname>Anuradha</surname><given-names>R</given-names></name><name><surname>Suresh</surname><given-names>R</given-names></name><name><surname>Ganesh</surname><given-names>R</given-names></name><name><surname>Shankar</surname><given-names>J</given-names></name><name><surname>Kumaraswami</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children</article-title>. <source>Clin Vaccine Immunol</source> (<year>2011</year>) <volume>18</volume>:<fpage>1856</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.05366-11</pub-id><?supplied-pmid 21955625?><pub-id pub-id-type="pmid">21955625</pub-id></mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunnari</surname><given-names>G</given-names></name><name><surname>Pinzone</surname><given-names>MR</given-names></name><name><surname>Vancheri</surname><given-names>C</given-names></name><name><surname>Palermo</surname><given-names>F</given-names></name><name><surname>Cacopardo</surname><given-names>B</given-names></name></person-group>
<article-title>Interferon-gamma and interleukin-17 production from PPD-stimulated PBMCs of patients with pulmonary tuberculosis</article-title>. <source>Clin Invest Med</source> (<year>2013</year>) <volume>36</volume>:<fpage>E64</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">23544607</pub-id></mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Guglani</surname><given-names>L</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Junecko</surname><given-names>BA</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>IL-23 is required for long-term control of <italic>Mycobacterium tuberculosis</italic> and B cell follicle formation in the infected lung</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>5402</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1101377</pub-id><?supplied-pmid 22003199?><pub-id pub-id-type="pmid">22003199</pub-id></mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freches</surname><given-names>D</given-names></name><name><surname>Korf</surname><given-names>H</given-names></name><name><surname>Denis</surname><given-names>O</given-names></name><name><surname>Havaux</surname><given-names>X</given-names></name><name><surname>Huygen</surname><given-names>K</given-names></name><name><surname>Romano</surname><given-names>M</given-names></name></person-group>. <article-title>Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunology</source> (<year>2013</year>) <volume>140</volume>:<fpage>220</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12130</pub-id><?supplied-pmid 23721367?><pub-id pub-id-type="pmid">23721367</pub-id></mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto Yoshida</surname><given-names>Y</given-names></name><name><surname>Umemura</surname><given-names>M</given-names></name><name><surname>Yahagi</surname><given-names>A</given-names></name><name><surname>O&#x02019;brien</surname><given-names>RL</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Kishihara</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>4414</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0903332</pub-id><pub-id pub-id-type="pmid">20212094</pub-id></mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Monin</surname><given-names>L</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Uche</surname><given-names>U</given-names></name><name><surname>Blanchard</surname><given-names>E</given-names></name><name><surname>Fallert Junecko</surname><given-names>BA</given-names></name><etal/></person-group>
<article-title>Unexpected role for IL-17 in protective immunity against hypervirulent <italic>Mycobacterium tuberculosis</italic> HN878 infection</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1004099</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004099</pub-id><?supplied-pmid 24831696?><pub-id pub-id-type="pmid">24831696</pub-id></mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umemura</surname><given-names>M</given-names></name><name><surname>Okamoto-Yoshida</surname><given-names>Y</given-names></name><name><surname>Yahagi</surname><given-names>A</given-names></name><name><surname>Touyama</surname><given-names>S</given-names></name><name><surname>Nakae</surname><given-names>S</given-names></name><name><surname>Iwakura</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Involvement of IL-17A-producing TCR gammadelta T cells in late protective immunity against pulmonary <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immun Inflamm Dis</source> (<year>2016</year>) <volume>4</volume>:<fpage>401</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1002/iid3.121</pub-id><pub-id pub-id-type="pmid">27980775</pub-id></mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Carragher</surname><given-names>DM</given-names></name><name><surname>De La Luz Garcia-Hernandez</surname><given-names>M</given-names></name><name><surname>Hwang</surname><given-names>JY</given-names></name><name><surname>Kusser</surname><given-names>K</given-names></name><name><surname>Hartson</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>The development of inducible bronchus-associated lymphoid tissue depends on IL-17</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>:<fpage>639</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2053</pub-id><?supplied-pmid 21666689?><pub-id pub-id-type="pmid">21666689</pub-id></mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>JY</given-names></name><name><surname>Randall</surname><given-names>TD</given-names></name><name><surname>Silva-Sanchez</surname><given-names>A</given-names></name></person-group>. <article-title>Inducible bronchus-associated lymphoid tissue: taming inflammation in the lung</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>258</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2016.00258</pub-id><?supplied-pmid 27446088?><pub-id pub-id-type="pmid">27446088</pub-id></mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slight</surname><given-names>SR</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Fallert Junecko</surname><given-names>BA</given-names></name><name><surname>Mehra</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>CXCR5(+) T helper cells mediate protective immunity against tuberculosis</article-title>. <source>J Clin Invest</source> (<year>2013</year>) <volume>123</volume>:<fpage>712</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1172/JCI65728</pub-id><pub-id pub-id-type="pmid">23281399</pub-id></mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>YA</given-names></name><name><surname>Blomgran-Julinder</surname><given-names>R</given-names></name><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Stendahl</surname><given-names>O</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic>-induced apoptotic neutrophils trigger a pro-inflammatory response in macrophages through release of heat shock protein 72, acting in synergy with the bacteria</article-title>. <source>Microbes Infect</source> (<year>2008</year>) <volume>10</volume>:<fpage>233</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2007.11.007</pub-id><?supplied-pmid 18328761?><pub-id pub-id-type="pmid">18328761</pub-id></mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedlund</surname><given-names>S</given-names></name><name><surname>Persson</surname><given-names>A</given-names></name><name><surname>Vujic</surname><given-names>A</given-names></name><name><surname>Che</surname><given-names>KF</given-names></name><name><surname>Stendahl</surname><given-names>O</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name></person-group>. <article-title>Dendritic cell activation by sensing <italic>Mycobacterium tuberculosis</italic>-induced apoptotic neutrophils via DC-SIGN</article-title>. <source>Hum Immunol</source> (<year>2010</year>) <volume>71</volume>:<fpage>535</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.humimm.2010.02.022</pub-id><?supplied-pmid 20219612?><pub-id pub-id-type="pmid">20219612</pub-id></mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braian</surname><given-names>C</given-names></name><name><surname>Hogea</surname><given-names>V</given-names></name><name><surname>Stendahl</surname><given-names>O</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic>-induced neutrophil extracellular traps activate human macrophages</article-title>. <source>J Innate Immun</source> (<year>2013</year>) <volume>5</volume>:<fpage>591</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1159/000348676</pub-id><?supplied-pmid 23635526?><pub-id pub-id-type="pmid">23635526</pub-id></mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>H</given-names></name><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Eklund</surname><given-names>D</given-names></name><name><surname>Ngoh</surname><given-names>E</given-names></name><name><surname>Persson</surname><given-names>A</given-names></name><name><surname>Svensson</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Apoptotic neutrophils augment the inflammatory response to <italic>Mycobacterium tuberculosis</italic> infection in human macrophages</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>e101514</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0101514</pub-id><?supplied-pmid 25000410?><pub-id pub-id-type="pmid">25000410</pub-id></mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trentini</surname><given-names>MM</given-names></name><name><surname>De Oliveira</surname><given-names>FM</given-names></name><name><surname>Kipnis</surname><given-names>A</given-names></name><name><surname>Junqueira-Kipnis</surname><given-names>AP</given-names></name></person-group>. <article-title>The role of neutrophils in the induction of specific Th1 and Th17 during vaccination against tuberculosis</article-title>. <source>Front Microbiol</source> (<year>2016</year>) <volume>7</volume>:<fpage>898</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2016.00898</pub-id><?supplied-pmid 27375607?><pub-id pub-id-type="pmid">27375607</pub-id></mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grainger</surname><given-names>JR</given-names></name><name><surname>Wohlfert</surname><given-names>EA</given-names></name><name><surname>Fuss</surname><given-names>IJ</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Askenase</surname><given-names>MH</given-names></name><name><surname>Legrand</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection</article-title>. <source>Nat Med</source> (<year>2013</year>) <volume>19</volume>:<fpage>713</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3189</pub-id><?supplied-pmid 23708291?><pub-id pub-id-type="pmid">23708291</pub-id></mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shishikura</surname><given-names>K</given-names></name><name><surname>Horiuchi</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>N</given-names></name><name><surname>Trinh</surname><given-names>DA</given-names></name><name><surname>Shirakawa</surname><given-names>R</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP</article-title>. <source>Br J Pharmacol</source> (<year>2016</year>) <volume>173</volume>:<fpage>319</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/bph.13373</pub-id><?supplied-pmid 26505736?><pub-id pub-id-type="pmid">26505736</pub-id></mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeve</surname><given-names>MA</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>De Boer</surname><given-names>T</given-names></name><name><surname>Langenberg</surname><given-names>DM</given-names></name><name><surname>De Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><etal/></person-group>
<article-title>Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells</article-title>. <source>Eur J Immunol</source> (<year>2006</year>) <volume>36</volume>:<fpage>661</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200535239</pub-id><?supplied-pmid 16482511?><pub-id pub-id-type="pmid">16482511</pub-id></mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monin</surname><given-names>L</given-names></name><name><surname>Griffiths</surname><given-names>KL</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name></person-group>. <article-title>Immune requirements for protective Th17 recall responses to <italic>Mycobacterium tuberculosis</italic> challenge</article-title>. <source>Mucosal Immunol</source> (<year>2015</year>) <volume>8</volume>:<fpage>1099</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2014.136</pub-id><?supplied-pmid 25627812?><pub-id pub-id-type="pmid">25627812</pub-id></mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Nawar</surname><given-names>HF</given-names></name><name><surname>Fallert Junecko</surname><given-names>BA</given-names></name><etal/></person-group>
<article-title>Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis</article-title>. <source>Mucosal Immunol</source> (<year>2013</year>) <volume>6</volume>:<fpage>972</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2012.135</pub-id><?supplied-pmid 23299616?><pub-id pub-id-type="pmid">23299616</pub-id></mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maione</surname><given-names>F</given-names></name><name><surname>Paschalidis</surname><given-names>N</given-names></name><name><surname>Mascolo</surname><given-names>N</given-names></name><name><surname>Dufton</surname><given-names>N</given-names></name><name><surname>Perretti</surname><given-names>M</given-names></name><name><surname>D&#x02019;acquisto</surname><given-names>F</given-names></name></person-group>. <article-title>Interleukin 17 sustains rather than induces inflammation</article-title>. <source>Biochem Pharmacol</source> (<year>2009</year>) <volume>77</volume>:<fpage>878</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.bcp.2008.11.011</pub-id><?supplied-pmid 19073154?><pub-id pub-id-type="pmid">19073154</pub-id></mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Nieuwenhuijze</surname><given-names>AEM</given-names></name><name><surname>Van De Loo</surname><given-names>FA</given-names></name><name><surname>Walgreen</surname><given-names>B</given-names></name><name><surname>Bennink</surname><given-names>M</given-names></name><name><surname>Helsen</surname><given-names>MMA</given-names></name><name><surname>Van Den Bersselaar</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>1.56 Synergism between GM-CSF and IL-17 causes enhanced joint pathology via the production of IL-6 and IL-23</article-title>. <source>Ann Rheum Dis</source> (<year>2014</year>) <volume>73</volume>:<fpage>A24</fpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2014-eular.5430</pub-id></mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Fraga</surname><given-names>AG</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Saraiva</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1609</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20100265</pub-id><?supplied-pmid 20624887?><pub-id pub-id-type="pmid">20624887</pub-id></mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottenberg</surname><given-names>ME</given-names></name><name><surname>Carow</surname><given-names>B</given-names></name></person-group>. <article-title>SOCS3 and STAT3, major controllers of the outcome of infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Semin Immunol</source> (<year>2014</year>) <volume>26</volume>:<fpage>518</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2014.10.004</pub-id><?supplied-pmid 25458989?><pub-id pub-id-type="pmid">25458989</pub-id></mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eum</surname><given-names>SY</given-names></name><name><surname>Kong</surname><given-names>JH</given-names></name><name><surname>Hong</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>SH</given-names></name><etal/></person-group>
<article-title>Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB</article-title>. <source>Chest</source> (<year>2010</year>) <volume>137</volume>:<fpage>122</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1378/chest.09-0903</pub-id><?supplied-pmid 19749004?><pub-id pub-id-type="pmid">19749004</pub-id></mixed-citation></ref><ref id="B217"><label>217</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisich</surname><given-names>KO</given-names></name><name><surname>Higgins</surname><given-names>M</given-names></name><name><surname>Diamond</surname><given-names>G</given-names></name><name><surname>Heifets</surname><given-names>L</given-names></name></person-group>. <article-title>Tumor necrosis factor alpha stimulates killing of <italic>Mycobacterium tuberculosis</italic> by human neutrophils</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>:<fpage>4591</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.70.8.4591-4599.2002</pub-id><?supplied-pmid 12117972?><pub-id pub-id-type="pmid">12117972</pub-id></mixed-citation></ref><ref id="B218"><label>218</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eruslanov</surname><given-names>EB</given-names></name><name><surname>Lyadova</surname><given-names>IV</given-names></name><name><surname>Kondratieva</surname><given-names>TK</given-names></name><name><surname>Majorov</surname><given-names>KB</given-names></name><name><surname>Scheglov</surname><given-names>IV</given-names></name><name><surname>Orlova</surname><given-names>MO</given-names></name><etal/></person-group>
<article-title>Neutrophil responses to <italic>Mycobacterium tuberculosis</italic> infection in genetically susceptible and resistant mice</article-title>. <source>Infect Immun</source> (<year>2005</year>) <volume>73</volume>:<fpage>1744</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.73.3.1744-1753.2005</pub-id><?supplied-pmid 15731075?><pub-id pub-id-type="pmid">15731075</pub-id></mixed-citation></ref><ref id="B219"><label>219</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Brandau</surname><given-names>S</given-names></name><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name></person-group>. <article-title>Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>4295</fpage>&#x02013;<lpage>309</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00057-06</pub-id><?supplied-pmid 16790804?><pub-id pub-id-type="pmid">16790804</pub-id></mixed-citation></ref><ref id="B220"><label>220</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Linge</surname><given-names>I</given-names></name><name><surname>Kondratieva</surname><given-names>T</given-names></name><name><surname>Apt</surname><given-names>A</given-names></name></person-group>. <article-title>Neutrophils exacerbate tuberculosis infection in genetically susceptible mice</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2015</year>) <volume>95</volume>:<fpage>447</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2015.03.007</pub-id><?supplied-pmid 25935122?><pub-id pub-id-type="pmid">25935122</pub-id></mixed-citation></ref><ref id="B221"><label>221</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Kaviratne</surname><given-names>M</given-names></name><name><surname>Rothfuchs</surname><given-names>AG</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>HA</given-names></name><etal/></person-group>
<article-title>NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>7086</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.10.7086</pub-id><?supplied-pmid 17082625?><pub-id pub-id-type="pmid">17082625</pub-id></mixed-citation></ref><ref id="B222"><label>222</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomgran</surname><given-names>R</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>. <article-title>Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>7110</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1100001</pub-id><?supplied-pmid 21555529?><pub-id pub-id-type="pmid">21555529</pub-id></mixed-citation></ref><ref id="B223"><label>223</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>HR</given-names></name><name><surname>Robb</surname><given-names>CT</given-names></name><name><surname>Perretti</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>AG</given-names></name></person-group>
<article-title>The role of neutrophils in inflammation resolution</article-title>. <source>Semin Immunol</source> (<year>2016</year>) <volume>28</volume>:<fpage>137</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2016.03.007</pub-id><pub-id pub-id-type="pmid">27021499</pub-id></mixed-citation></ref><ref id="B224"><label>224</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doz</surname><given-names>E</given-names></name><name><surname>Lombard</surname><given-names>R</given-names></name><name><surname>Carreras</surname><given-names>F</given-names></name><name><surname>Buzoni-Gatel</surname><given-names>D</given-names></name><name><surname>Winter</surname><given-names>N</given-names></name></person-group>. <article-title>Mycobacteria-infected dendritic cells attract neutrophils that produce IL-10 and specifically shut down Th17 CD4 T cells through their IL-10 receptor</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<fpage>3818</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1300527</pub-id><?supplied-pmid 23997221?><pub-id pub-id-type="pmid">23997221</pub-id></mixed-citation></ref><ref id="B225"><label>225</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Deriaud</surname><given-names>E</given-names></name><name><surname>Leclerc</surname><given-names>C</given-names></name><name><surname>Lo-Man</surname><given-names>R</given-names></name></person-group>. <article-title>Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>:<fpage>761</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.09.016</pub-id><?supplied-pmid 19913447?><pub-id pub-id-type="pmid">19913447</pub-id></mixed-citation></ref><ref id="B226"><label>226</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zizzo</surname><given-names>G</given-names></name><name><surname>Cohen</surname><given-names>PL</given-names></name></person-group>. <article-title>IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>5237</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1203017</pub-id><?supplied-pmid 23596310?><pub-id pub-id-type="pmid">23596310</pub-id></mixed-citation></ref><ref id="B227"><label>227</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Pulmonary resident neutrophils regulate the production of GM-CSF and alveolar macrophages</article-title>. <source>FEBS J</source> (<year>2016</year>) <volume>283</volume>:<fpage>1465</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1111/febs.13684</pub-id><?supplied-pmid 26881904?><pub-id pub-id-type="pmid">26881904</pub-id></mixed-citation></ref><ref id="B228"><label>228</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragon</surname><given-names>S</given-names></name><name><surname>Saffar</surname><given-names>AS</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Gounni</surname><given-names>AS</given-names></name></person-group>. <article-title>IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils</article-title>. <source>Mol Immunol</source> (<year>2008</year>) <volume>45</volume>:<fpage>160</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2007.04.027</pub-id><?supplied-pmid 17555818?><pub-id pub-id-type="pmid">17555818</pub-id></mixed-citation></ref><ref id="B229"><label>229</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverpil</surname><given-names>E</given-names></name><name><surname>Glader</surname><given-names>P</given-names></name><name><surname>Hansson</surname><given-names>M</given-names></name><name><surname>Linden</surname><given-names>A</given-names></name></person-group>. <article-title>Impact of interleukin-17 on macrophage phagocytosis of apoptotic neutrophils and particles</article-title>. <source>Inflammation</source> (<year>2011</year>) <volume>34</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/s10753-010-9201-8</pub-id><?supplied-pmid 20339909?><pub-id pub-id-type="pmid">20339909</pub-id></mixed-citation></ref><ref id="B230"><label>230</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grogan</surname><given-names>JL</given-names></name><name><surname>Ouyang</surname><given-names>W</given-names></name></person-group>. <article-title>A role for Th17&#x02009;cells in the regulation of tertiary lymphoid follicles</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>2255</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201242656</pub-id><?supplied-pmid 22949324?><pub-id pub-id-type="pmid">22949324</pub-id></mixed-citation></ref><ref id="B231"><label>231</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkes</surname><given-names>M</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Van Heel</surname><given-names>DA</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name></person-group>. <article-title>Genetic insights into common pathways and complex relationships among immune-mediated diseases</article-title>. <source>Nat Rev Genet</source> (<year>2013</year>) <volume>14</volume>:<fpage>661</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/nrg3502</pub-id><?supplied-pmid 23917628?><pub-id pub-id-type="pmid">23917628</pub-id></mixed-citation></ref><ref id="B232"><label>232</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>BW</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>White</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>White</surname><given-names>WI</given-names></name><name><surname>Morehouse</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway</article-title>. <source>Ann Rheum Dis</source> (<year>2011</year>) <volume>70</volume>:<fpage>2029</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1136/ard.2011.150326</pub-id><?supplied-pmid 21803750?><pub-id pub-id-type="pmid">21803750</pub-id></mixed-citation></ref><ref id="B233"><label>233</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahren-Herlenius</surname><given-names>M</given-names></name><name><surname>Dorner</surname><given-names>T</given-names></name></person-group>. <article-title>Immunopathogenic mechanisms of systemic autoimmune disease</article-title>. <source>Lancet</source> (<year>2013</year>) <volume>382</volume>:<fpage>819</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60954-X</pub-id><?supplied-pmid 23993191?><pub-id pub-id-type="pmid">23993191</pub-id></mixed-citation></ref><ref id="B234"><label>234</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brkic</surname><given-names>Z</given-names></name><name><surname>Versnel</surname><given-names>MA</given-names></name></person-group>
<article-title>Type I IFN signature in primary Sjogren&#x02019;s syndrome patients</article-title>. <source>Expert Rev Clin Immunol</source> (<year>2014</year>) <volume>10</volume>:<fpage>457</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1586/1744666X.2014.876364</pub-id><pub-id pub-id-type="pmid">24450331</pub-id></mixed-citation></ref><ref id="B235"><label>235</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Batliwalla</surname><given-names>FM</given-names></name><name><surname>Karypis</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Ortmann</surname><given-names>WA</given-names></name><name><surname>Espe</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>:<fpage>2610</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0337679100</pub-id><?supplied-pmid 12604793?><pub-id pub-id-type="pmid">12604793</pub-id></mixed-citation></ref><ref id="B236"><label>236</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>L</given-names></name><name><surname>Palucka</surname><given-names>AK</given-names></name><name><surname>Arce</surname><given-names>E</given-names></name><name><surname>Cantrell</surname><given-names>V</given-names></name><name><surname>Borvak</surname><given-names>J</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Interferon and granulopoiesis signatures in systemic lupus erythematosus blood</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>197</volume>:<fpage>711</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20021553</pub-id><?supplied-pmid 12642603?><pub-id pub-id-type="pmid">12642603</pub-id></mixed-citation></ref><ref id="B237"><label>237</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Louca</surname><given-names>K</given-names></name><name><surname>Peterson</surname><given-names>MG</given-names></name><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>. <article-title>Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease</article-title>. <source>Arthritis Rheum</source> (<year>2005</year>) <volume>52</volume>:<fpage>1491</fpage>&#x02013;<lpage>503</lpage>.<pub-id pub-id-type="doi">10.1002/art.21031</pub-id><?supplied-pmid 15880830?><pub-id pub-id-type="pmid">15880830</pub-id></mixed-citation></ref><ref id="B238"><label>238</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brkic</surname><given-names>Z</given-names></name><name><surname>Maria</surname><given-names>NI</given-names></name><name><surname>Van Helden-Meeuwsen</surname><given-names>CG</given-names></name><name><surname>Van De Merwe</surname><given-names>JP</given-names></name><name><surname>Van Daele</surname><given-names>PL</given-names></name><name><surname>Dalm</surname><given-names>VA</given-names></name><etal/></person-group>
<article-title>Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren&#x02019;s syndrome and association with disease activity and BAFF gene expression</article-title>. <source>Ann Rheum Dis</source> (<year>2013</year>) <volume>72</volume>:<fpage>728</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1136/annrheumdis-2012-201381</pub-id><?supplied-pmid 22736090?><pub-id pub-id-type="pmid">22736090</pub-id></mixed-citation></ref><ref id="B239"><label>239</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afshar</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>AD</given-names></name><name><surname>Gallo</surname><given-names>RL</given-names></name><name><surname>Hata</surname><given-names>TR</given-names></name></person-group>. <article-title>Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases</article-title>. <source>J Eur Acad Dermatol Venereol</source> (<year>2013</year>) <volume>27</volume>:<fpage>771</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-3083.2012.04582.x</pub-id><?supplied-pmid 22671985?><pub-id pub-id-type="pmid">22671985</pub-id></mixed-citation></ref><ref id="B240"><label>240</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb-Maurer</surname><given-names>A</given-names></name><name><surname>Goebeler</surname><given-names>M</given-names></name><name><surname>Maurer</surname><given-names>M</given-names></name></person-group>
<article-title>Cutaneous adverse events associated with interferon-beta treatment of multiple sclerosis</article-title>. <source>Int J Mol Sci</source> (<year>2015</year>) <volume>16</volume>:<fpage>14951</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.3390/ijms160714951</pub-id><pub-id pub-id-type="pmid">26147425</pub-id></mixed-citation></ref><ref id="B241"><label>241</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JC</given-names></name><name><surname>Baeten</surname><given-names>DL</given-names></name><name><surname>Josien</surname><given-names>R</given-names></name></person-group>. <article-title>Emerging role of IL-17 and Th17&#x02009;cells in systemic lupus erythematosus</article-title>. <source>Clin Immunol</source> (<year>2014</year>) <volume>154</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.clim.2014.05.004</pub-id><?supplied-pmid 24858580?><pub-id pub-id-type="pmid">24858580</pub-id></mixed-citation></ref><ref id="B242"><label>242</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axtell</surname><given-names>RC</given-names></name><name><surname>Raman</surname><given-names>C</given-names></name><name><surname>Steinman</surname><given-names>L</given-names></name></person-group>. <article-title>Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity</article-title>. <source>Clin Rev Allergy Immunol</source> (<year>2013</year>) <volume>44</volume>:<fpage>114</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1007/s12016-011-8296-5</pub-id><?supplied-pmid 22231516?><pub-id pub-id-type="pmid">22231516</pub-id></mixed-citation></ref><ref id="B243"><label>243</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>I</given-names></name><name><surname>Nalawade</surname><given-names>S</given-names></name><name><surname>Eagar</surname><given-names>TN</given-names></name><name><surname>Forsthuber</surname><given-names>TG</given-names></name></person-group>. <article-title>T cell subsets and their signature cytokines in autoimmune and inflammatory diseases</article-title>. <source>Cytokine</source> (<year>2015</year>) <volume>74</volume>:<fpage>5</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2014.09.011</pub-id><?supplied-pmid 25458968?><pub-id pub-id-type="pmid">25458968</pub-id></mixed-citation></ref><ref id="B244"><label>244</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>A</given-names></name><name><surname>Espinosa</surname><given-names>A</given-names></name><name><surname>Wahren-Herlenius</surname><given-names>M</given-names></name></person-group>. <article-title>IL-17: a new actor in IFN-driven systemic autoimmune diseases</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>2274</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201242653</pub-id><?supplied-pmid 22949326?><pub-id pub-id-type="pmid">22949326</pub-id></mixed-citation></ref><ref id="B245"><label>245</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>. <article-title>Type I interferon in the pathogenesis of lupus</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>5459</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1002795</pub-id><?supplied-pmid 24907379?><pub-id pub-id-type="pmid">24907379</pub-id></mixed-citation></ref><ref id="B246"><label>246</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niewold</surname><given-names>TB</given-names></name><name><surname>Hua</surname><given-names>J</given-names></name><name><surname>Lehman</surname><given-names>TJ</given-names></name><name><surname>Harley</surname><given-names>JB</given-names></name><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>. <article-title>High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus</article-title>. <source>Genes Immun</source> (<year>2007</year>) <volume>8</volume>:<fpage>492</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="doi">10.1038/sj.gene.6364408</pub-id><?supplied-pmid 17581626?><pub-id pub-id-type="pmid">17581626</pub-id></mixed-citation></ref><ref id="B247"><label>247</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkas</surname><given-names>L</given-names></name><name><surname>Beiske</surname><given-names>K</given-names></name><name><surname>Lund-Johansen</surname><given-names>F</given-names></name><name><surname>Brandtzaeg</surname><given-names>P</given-names></name><name><surname>Jahnsen</surname><given-names>FL</given-names></name></person-group>. <article-title>Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions</article-title>. <source>Am J Pathol</source> (<year>2001</year>) <volume>159</volume>:<fpage>237</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/S0002-9440(10)61689-6</pub-id><?supplied-pmid 11438470?><pub-id pub-id-type="pmid">11438470</pub-id></mixed-citation></ref><ref id="B248"><label>248</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnblom</surname><given-names>L</given-names></name><name><surname>Eloranta</surname><given-names>ML</given-names></name><name><surname>Alm</surname><given-names>GV</given-names></name></person-group>
<article-title>Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity</article-title>. <source>Autoimmunity</source> (<year>2003</year>) <volume>36</volume>:<fpage>463</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1080/08916930310001602128</pub-id><pub-id pub-id-type="pmid">14984023</pub-id></mixed-citation></ref><ref id="B249"><label>249</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Avalos</surname><given-names>AM</given-names></name><name><surname>Mao</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Senthil</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<fpage>487</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1038/ni1457</pub-id><?supplied-pmid 17417641?><pub-id pub-id-type="pmid">17417641</pub-id></mixed-citation></ref><ref id="B250"><label>250</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Romo</surname><given-names>GS</given-names></name><name><surname>Caielli</surname><given-names>S</given-names></name><name><surname>Vega</surname><given-names>B</given-names></name><name><surname>Connolly</surname><given-names>J</given-names></name><name><surname>Allantaz</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus</article-title>. <source>Sci Transl Med</source> (<year>2011</year>) <volume>3</volume>:<fpage>73ra20</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3001201</pub-id><?supplied-pmid 21389264?><pub-id pub-id-type="pmid">21389264</pub-id></mixed-citation></ref><ref id="B251"><label>251</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaffidi</surname><given-names>P</given-names></name><name><surname>Misteli</surname><given-names>T</given-names></name><name><surname>Bianchi</surname><given-names>ME</given-names></name></person-group>. <article-title>Release of chromatin protein HMGB1 by necrotic cells triggers inflammation</article-title>. <source>Nature</source> (<year>2002</year>) <volume>418</volume>:<fpage>191</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature00858</pub-id><?supplied-pmid 12110890?><pub-id pub-id-type="pmid">12110890</pub-id></mixed-citation></ref><ref id="B252"><label>252</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huebener</surname><given-names>P</given-names></name><name><surname>Pradere</surname><given-names>JP</given-names></name><name><surname>Hernandez</surname><given-names>C</given-names></name><name><surname>Gwak</surname><given-names>GY</given-names></name><name><surname>Caviglia</surname><given-names>JM</given-names></name><name><surname>Mu</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis</article-title>. <source>J Clin Invest</source> (<year>2015</year>) <volume>125</volume>:<fpage>539</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1172/JCI76887</pub-id><?supplied-pmid 25562324?><pub-id pub-id-type="pmid">25562324</pub-id></mixed-citation></ref><ref id="B253"><label>253</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lande</surname><given-names>R</given-names></name><name><surname>Ganguly</surname><given-names>D</given-names></name><name><surname>Facchinetti</surname><given-names>V</given-names></name><name><surname>Frasca</surname><given-names>L</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Gregorio</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus</article-title>. <source>Sci Transl Med</source> (<year>2011</year>) <volume>3</volume>:<fpage>73ra19</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3001180</pub-id><?supplied-pmid 21389263?><pub-id pub-id-type="pmid">21389263</pub-id></mixed-citation></ref><ref id="B254"><label>254</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjornsdottir</surname><given-names>H</given-names></name><name><surname>Welin</surname><given-names>A</given-names></name><name><surname>Michaelsson</surname><given-names>E</given-names></name><name><surname>Osla</surname><given-names>V</given-names></name><name><surname>Berg</surname><given-names>S</given-names></name><name><surname>Christenson</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Neutrophil NET formation is regulated from the inside by myeloperoxidase-processed reactive oxygen species</article-title>. <source>Free Radic Biol Med</source> (<year>2015</year>) <volume>89</volume>:<fpage>1024</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.10.398</pub-id><?supplied-pmid 26459032?><pub-id pub-id-type="pmid">26459032</pub-id></mixed-citation></ref><ref id="B255"><label>255</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Kashgarian</surname><given-names>M</given-names></name><name><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group>. <article-title>NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus</article-title>. <source>Sci Transl Med</source> (<year>2012</year>) <volume>4</volume>:<fpage>157ra141</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3004801</pub-id><?supplied-pmid 23100627?><pub-id pub-id-type="pmid">23100627</pub-id></mixed-citation></ref><ref id="B256"><label>256</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lood</surname><given-names>C</given-names></name><name><surname>Blanco</surname><given-names>LP</given-names></name><name><surname>Purmalek</surname><given-names>MM</given-names></name><name><surname>Carmona-Rivera</surname><given-names>C</given-names></name><name><surname>De Ravin</surname><given-names>SS</given-names></name><name><surname>Smith</surname><given-names>CK</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease</article-title>. <source>Nat Med</source> (<year>2016</year>) <volume>22</volume>:<fpage>146</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4027</pub-id><?supplied-pmid 26779811?><pub-id pub-id-type="pmid">26779811</pub-id></mixed-citation></ref><ref id="B257"><label>257</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>D</given-names></name><name><surname>Haak</surname><given-names>S</given-names></name><name><surname>Sisirak</surname><given-names>V</given-names></name><name><surname>Reizis</surname><given-names>B</given-names></name></person-group>. <article-title>The role of dendritic cells in autoimmunity</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>566</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1038/nri3477</pub-id><?supplied-pmid 23827956?><pub-id pub-id-type="pmid">23827956</pub-id></mixed-citation></ref><ref id="B258"><label>258</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>P</given-names></name><name><surname>Palucka</surname><given-names>AK</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name></person-group>. <article-title>Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus</article-title>. <source>Science</source> (<year>2001</year>) <volume>294</volume>:<fpage>1540</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1126/science.1064890</pub-id><?supplied-pmid 11711679?><pub-id pub-id-type="pmid">11711679</pub-id></mixed-citation></ref><ref id="B259"><label>259</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnblom</surname><given-names>L</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name></person-group>. <article-title>The innate immune system in SLE: type I interferons and dendritic cells</article-title>. <source>Lupus</source> (<year>2008</year>) <volume>17</volume>:<fpage>394</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1177/0961203308090020</pub-id><?supplied-pmid 18490415?><pub-id pub-id-type="pmid">18490415</pub-id></mixed-citation></ref><ref id="B260"><label>260</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>FB</given-names></name><name><surname>Morand</surname><given-names>EF</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name></person-group>. <article-title>The BAFF/APRIL system in SLE pathogenesis</article-title>. <source>Nat Rev Rheumatol</source> (<year>2014</year>) <volume>10</volume>:<fpage>365</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2014.33</pub-id><?supplied-pmid 24614588?><pub-id pub-id-type="pmid">24614588</pub-id></mixed-citation></ref><ref id="B261"><label>261</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjostrand</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>A</given-names></name><name><surname>Aqrawi</surname><given-names>L</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Wahren-Herlenius</surname><given-names>M</given-names></name><name><surname>Espinosa</surname><given-names>A</given-names></name></person-group>. <article-title>The expression of BAFF is controlled by IRF transcription factors</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>:<fpage>91</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1501061</pub-id><?supplied-pmid 26590315?><pub-id pub-id-type="pmid">26590315</pub-id></mixed-citation></ref><ref id="B262"><label>262</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Mathian</surname><given-names>A</given-names></name><name><surname>Koss</surname><given-names>MN</given-names></name><name><surname>Gindea</surname><given-names>S</given-names></name><name><surname>Putterman</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>B cell and BAFF dependence of IFN-alpha-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>4984</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1000466</pub-id><pub-id pub-id-type="pmid">21383240</pub-id></mixed-citation></ref><ref id="B263"><label>263</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zollars</surname><given-names>E</given-names></name><name><surname>Bienkowska</surname><given-names>J</given-names></name><name><surname>Czerkowicz</surname><given-names>J</given-names></name><name><surname>Allaire</surname><given-names>N</given-names></name><name><surname>Ranger</surname><given-names>AM</given-names></name><name><surname>Magder</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year</article-title>. <source>Lupus Sci Med</source> (<year>2015</year>) <volume>2</volume>:<fpage>e000063</fpage>.<pub-id pub-id-type="doi">10.1136/lupus-2014-000063</pub-id><?supplied-pmid 26113988?><pub-id pub-id-type="pmid">26113988</pub-id></mixed-citation></ref><ref id="B264"><label>264</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litinskiy</surname><given-names>MB</given-names></name><name><surname>Nardelli</surname><given-names>B</given-names></name><name><surname>Hilbert</surname><given-names>DM</given-names></name><name><surname>He</surname><given-names>B</given-names></name><name><surname>Schaffer</surname><given-names>A</given-names></name><name><surname>Casali</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL</article-title>. <source>Nat Immunol</source> (<year>2002</year>) <volume>3</volume>:<fpage>822</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni829</pub-id><?supplied-pmid 12154359?><pub-id pub-id-type="pmid">12154359</pub-id></mixed-citation></ref><ref id="B265"><label>265</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarra</surname><given-names>SV</given-names></name><name><surname>Guzman</surname><given-names>RM</given-names></name><name><surname>Gallacher</surname><given-names>AE</given-names></name><name><surname>Hall</surname><given-names>S</given-names></name><name><surname>Levy</surname><given-names>RA</given-names></name><name><surname>Jimenez</surname><given-names>RE</given-names></name><etal/></person-group>
<article-title>Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial</article-title>. <source>Lancet</source> (<year>2011</year>) <volume>377</volume>:<fpage>721</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(10)61354-2</pub-id><?supplied-pmid 21296403?><pub-id pub-id-type="pmid">21296403</pub-id></mixed-citation></ref><ref id="B266"><label>266</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrill</surname><given-names>JT</given-names></name><name><surname>Neuwelt</surname><given-names>CM</given-names></name><name><surname>Wallace</surname><given-names>DJ</given-names></name><name><surname>Shanahan</surname><given-names>JC</given-names></name><name><surname>Latinis</surname><given-names>KM</given-names></name><name><surname>Oates</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial</article-title>. <source>Arthritis Rheum</source> (<year>2010</year>) <volume>62</volume>:<fpage>222</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1002/art.27233</pub-id><?supplied-pmid 20039413?><pub-id pub-id-type="pmid">20039413</pub-id></mixed-citation></ref><ref id="B267"><label>267</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Furie</surname><given-names>R</given-names></name><name><surname>Latinis</surname><given-names>K</given-names></name><name><surname>Looney</surname><given-names>RJ</given-names></name><name><surname>Fervenza</surname><given-names>FC</given-names></name><name><surname>Sanchez-Guerrero</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study</article-title>. <source>Arthritis Rheum</source> (<year>2012</year>) <volume>64</volume>:<fpage>1215</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1002/art.34359</pub-id><?supplied-pmid 22231479?><pub-id pub-id-type="pmid">22231479</pub-id></mixed-citation></ref><ref id="B268"><label>268</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Lan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>YP</given-names></name><etal/></person-group>
<article-title>BAFF promotes Th17&#x02009;cells and aggravates experimental autoimmune encephalomyelitis</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<fpage>e23629</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0023629</pub-id><?supplied-pmid 21897850?><pub-id pub-id-type="pmid">21897850</pub-id></mixed-citation></ref><ref id="B269"><label>269</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munari</surname><given-names>F</given-names></name><name><surname>Fassan</surname><given-names>M</given-names></name><name><surname>Capitani</surname><given-names>N</given-names></name><name><surname>Codolo</surname><given-names>G</given-names></name><name><surname>Vila-Caballer</surname><given-names>M</given-names></name><name><surname>Pizzi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Cytokine BAFF released by <italic>Helicobacter pylori</italic>-infected macrophages triggers the Th17 response in human chronic gastritis</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>5584</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1302865</pub-id><?supplied-pmid 25339679?><pub-id pub-id-type="pmid">25339679</pub-id></mixed-citation></ref><ref id="B270"><label>270</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>MJ</given-names></name><name><surname>Dillon</surname><given-names>SR</given-names></name><name><surname>Castigli</surname><given-names>E</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Lam</surname><given-names>KP</given-names></name><etal/></person-group>
<article-title>Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<fpage>3655</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.180.6.3655</pub-id><?supplied-pmid 18322170?><pub-id pub-id-type="pmid">18322170</pub-id></mixed-citation></ref><ref id="B271"><label>271</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsa</surname><given-names>R</given-names></name><name><surname>Lund</surname><given-names>H</given-names></name><name><surname>Georgoudaki</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Ortlieb Guerreiro-Cacais</surname><given-names>A</given-names></name><name><surname>Grommisch</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>:<fpage>1537</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20150577</pub-id><?supplied-pmid 27432941?><pub-id pub-id-type="pmid">27432941</pub-id></mixed-citation></ref><ref id="B272"><label>272</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langrish</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Blumenschein</surname><given-names>WM</given-names></name><name><surname>Mattson</surname><given-names>J</given-names></name><name><surname>Basham</surname><given-names>B</given-names></name><name><surname>Sedgwick</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>IL-23 drives a pathogenic T cell population that induces autoimmune inflammation</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>:<fpage>233</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20041257</pub-id><?supplied-pmid 15657292?><pub-id pub-id-type="pmid">15657292</pub-id></mixed-citation></ref><ref id="B273"><label>273</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noster</surname><given-names>R</given-names></name><name><surname>Riedel</surname><given-names>R</given-names></name><name><surname>Mashreghi</surname><given-names>MF</given-names></name><name><surname>Radbruch</surname><given-names>H</given-names></name><name><surname>Harms</surname><given-names>L</given-names></name><name><surname>Haftmann</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells</article-title>. <source>Sci Transl Med</source> (<year>2014</year>) <volume>6</volume>:<fpage>241ra280</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3008706</pub-id><?supplied-pmid 24944195?><pub-id pub-id-type="pmid">24944195</pub-id></mixed-citation></ref><ref id="B274"><label>274</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Rezk</surname><given-names>A</given-names></name><name><surname>Miyazaki</surname><given-names>Y</given-names></name><name><surname>Hilgenberg</surname><given-names>E</given-names></name><name><surname>Touil</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy</article-title>. <source>Sci Transl Med</source> (<year>2015</year>) <volume>7</volume>:<fpage>310ra166</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aab4176</pub-id><?supplied-pmid 26491076?><pub-id pub-id-type="pmid">26491076</pub-id></mixed-citation></ref><ref id="B275"><label>275</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasouli</surname><given-names>J</given-names></name><name><surname>Ciric</surname><given-names>B</given-names></name><name><surname>Imitola</surname><given-names>J</given-names></name><name><surname>Gonnella</surname><given-names>P</given-names></name><name><surname>Hwang</surname><given-names>D</given-names></name><name><surname>Mahajan</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Expression of GM-CSF in T Cells is increased in multiple sclerosis and suppressed by IFN-beta therapy</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>5085</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1403243</pub-id><pub-id pub-id-type="pmid">25917097</pub-id></mixed-citation></ref><ref id="B276"><label>276</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>SJ</given-names></name><name><surname>Guzman</surname><given-names>AA</given-names></name><name><surname>Frohman</surname><given-names>EM</given-names></name><name><surname>Monson</surname><given-names>NL</given-names></name></person-group>. <article-title>B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses</article-title>. <source>J Neuroimmunol</source> (<year>2016</year>) <volume>291</volume>:<fpage>46</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.11.022</pub-id><?supplied-pmid 26857494?><pub-id pub-id-type="pmid">26857494</pub-id></mixed-citation></ref><ref id="B277"><label>277</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Ivanov</surname><given-names>II</given-names></name><name><surname>Spolski</surname><given-names>R</given-names></name><name><surname>Min</surname><given-names>R</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Egawa</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<fpage>967</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/ni1488</pub-id><?supplied-pmid 17581537?><pub-id pub-id-type="pmid">17581537</pub-id></mixed-citation></ref><ref id="B278"><label>278</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>XO</given-names></name><name><surname>Chung</surname><given-names>Y</given-names></name><name><surname>Fukunaga</surname><given-names>A</given-names></name><name><surname>Nurieva</surname><given-names>R</given-names></name><name><surname>Pappu</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>CCR6 regulates the migration of inflammatory and regulatory T cells</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>8391</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.12.8391</pub-id><?supplied-pmid 19050256?><pub-id pub-id-type="pmid">19050256</pub-id></mixed-citation></ref><ref id="B279"><label>279</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croxford</surname><given-names>AL</given-names></name><name><surname>Lanzinger</surname><given-names>M</given-names></name><name><surname>Hartmann</surname><given-names>FJ</given-names></name><name><surname>Schreiner</surname><given-names>B</given-names></name><name><surname>Mair</surname><given-names>F</given-names></name><name><surname>Pelczar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>:<fpage>502</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.010</pub-id><?supplied-pmid 26341401?><pub-id pub-id-type="pmid">26341401</pub-id></mixed-citation></ref><ref id="B280"><label>280</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schett</surname><given-names>G</given-names></name><name><surname>Dayer</surname><given-names>JM</given-names></name><name><surname>Manger</surname><given-names>B</given-names></name></person-group>. <article-title>Interleukin-1 function and role in rheumatic disease</article-title>. <source>Nat Rev Rheumatol</source> (<year>2016</year>) <volume>12</volume>:<fpage>14</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2016.166</pub-id><?supplied-pmid 26656658?><pub-id pub-id-type="pmid">26656658</pub-id></mixed-citation></ref><ref id="B281"><label>281</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avci</surname><given-names>AB</given-names></name><name><surname>Feist</surname><given-names>E</given-names></name><name><surname>Burmester</surname><given-names>GR</given-names></name></person-group>
<article-title>Targeting GM-CSF in rheumatoid arthritis</article-title>. <source>Clin Exp Rheumatol</source> (<year>2016</year>) <volume>34</volume>:<fpage>39</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">27586802</pub-id></mixed-citation></ref><ref id="B282"><label>282</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canavan</surname><given-names>TN</given-names></name><name><surname>Elmets</surname><given-names>CA</given-names></name><name><surname>Cantrell</surname><given-names>WL</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><name><surname>Elewski</surname><given-names>BE</given-names></name></person-group>. <article-title>Anti-IL-17 medications used in the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review</article-title>. <source>Am J Clin Dermatol</source> (<year>2016</year>) <volume>17</volume>:<fpage>33</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1007/s40257-015-0162-4</pub-id><?supplied-pmid 26649440?><pub-id pub-id-type="pmid">26649440</pub-id></mixed-citation></ref><ref id="B283"><label>283</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amarilyo</surname><given-names>G</given-names></name><name><surname>Lourenco</surname><given-names>EV</given-names></name><name><surname>Shi</surname><given-names>FD</given-names></name><name><surname>La Cava</surname><given-names>A</given-names></name></person-group>. <article-title>IL-17 promotes murine lupus</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>540</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1400931</pub-id><?supplied-pmid 24920843?><pub-id pub-id-type="pmid">24920843</pub-id></mixed-citation></ref><ref id="B284"><label>284</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnason</surname><given-names>BG</given-names></name></person-group>. <article-title>Immunologic therapy of multiple sclerosis</article-title>. <source>Annu Rev Med</source> (<year>1999</year>) <volume>50</volume>:<fpage>291</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.med.50.1.291</pub-id><?supplied-pmid 10073279?><pub-id pub-id-type="pmid">10073279</pub-id></mixed-citation></ref><ref id="B285"><label>285</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczucinski</surname><given-names>A</given-names></name><name><surname>Losy</surname><given-names>J</given-names></name></person-group>. <article-title>Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis</article-title>. <source>Folia Neuropathol</source> (<year>2004</year>) <volume>42</volume>:<fpage>15</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 15119740?><pub-id pub-id-type="pmid">15119740</pub-id></mixed-citation></ref><ref id="B286"><label>286</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiomi</surname><given-names>A</given-names></name><name><surname>Usui</surname><given-names>T</given-names></name></person-group>. <article-title>Pivotal roles of GM-CSF in autoimmunity and inflammation</article-title>. <source>Mediators Inflamm</source> (<year>2015</year>) <volume>2015</volume>:<fpage>568543</fpage>.<pub-id pub-id-type="doi">10.1155/2015/568543</pub-id><?supplied-pmid 25838639?><pub-id pub-id-type="pmid">25838639</pub-id></mixed-citation></ref><ref id="B287"><label>287</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ifergan</surname><given-names>I</given-names></name><name><surname>Kebir</surname><given-names>H</given-names></name><name><surname>Bernard</surname><given-names>M</given-names></name><name><surname>Wosik</surname><given-names>K</given-names></name><name><surname>Dodelet-Devillers</surname><given-names>A</given-names></name><name><surname>Cayrol</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells</article-title>. <source>Brain</source> (<year>2008</year>) <volume>131</volume>:<fpage>785</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1093/brain/awm295</pub-id><?supplied-pmid 18156156?><pub-id pub-id-type="pmid">18156156</pub-id></mixed-citation></ref><ref id="B288"><label>288</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>P</given-names></name></person-group>
<article-title>Neutrophils and interferon-alpha-producing cells: who produces interferon in lupus?</article-title>
<source>Arthritis Res Ther</source> (<year>2011</year>) <volume>13</volume>:<fpage>118</fpage><pub-id pub-id-type="doi">10.1186/ar3345</pub-id><pub-id pub-id-type="pmid">21745418</pub-id></mixed-citation></ref><ref id="B289"><label>289</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindau</surname><given-names>D</given-names></name><name><surname>Mussard</surname><given-names>J</given-names></name><name><surname>Rabsteyn</surname><given-names>A</given-names></name><name><surname>Ribon</surname><given-names>M</given-names></name><name><surname>Kotter</surname><given-names>I</given-names></name><name><surname>Igney</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen</article-title>. <source>Ann Rheum Dis</source> (<year>2014</year>) <volume>73</volume>:<fpage>2199</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="doi">10.1136/annrheumdis-2012-203041</pub-id><pub-id pub-id-type="pmid">24013727</pub-id></mixed-citation></ref><ref id="B290"><label>290</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demers</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>Gallant</surname><given-names>M</given-names></name><name><surname>Cabral</surname><given-names>JE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Priming of neutrophils toward NETosis promotes tumor growth</article-title>. <source>Oncoimmunology</source> (<year>2016</year>) <volume>5</volume>:<fpage>e1134073</fpage>.<pub-id pub-id-type="doi">10.1080/2162402X.2015.1134073</pub-id><?supplied-pmid 27467952?><pub-id pub-id-type="pmid">27467952</pub-id></mixed-citation></ref><ref id="B291"><label>291</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona-Rivera</surname><given-names>C</given-names></name><name><surname>Kaplan</surname><given-names>MJ</given-names></name></person-group>. <article-title>Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity</article-title>. <source>Semin Immunopathol</source> (<year>2013</year>) <volume>35</volume>:<fpage>455</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1007/s00281-013-0375-7</pub-id><?supplied-pmid 23553215?><pub-id pub-id-type="pmid">23553215</pub-id></mixed-citation></ref><ref id="B292"><label>292</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midgley</surname><given-names>A</given-names></name><name><surname>Beresford</surname><given-names>MW</given-names></name></person-group>. <article-title>Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity</article-title>. <source>Lupus</source> (<year>2016</year>) <volume>25</volume>:<fpage>407</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1177/0961203315608959</pub-id><?supplied-pmid 26453665?><pub-id pub-id-type="pmid">26453665</pub-id></mixed-citation></ref><ref id="B293"><label>293</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pers</surname><given-names>JO</given-names></name><name><surname>Daridon</surname><given-names>C</given-names></name><name><surname>Devauchelle</surname><given-names>V</given-names></name><name><surname>Jousse</surname><given-names>S</given-names></name><name><surname>Saraux</surname><given-names>A</given-names></name><name><surname>Jamin</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>BAFF overexpression is associated with autoantibody production in autoimmune diseases</article-title>. <source>Ann N Y Acad Sci</source> (<year>2005</year>) <volume>1050</volume>:<fpage>34</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1196/annals.1313.004</pub-id><?supplied-pmid 16014518?><pub-id pub-id-type="pmid">16014518</pub-id></mixed-citation></ref><ref id="B294"><label>294</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scapini</surname><given-names>P</given-names></name><name><surname>Bazzoni</surname><given-names>F</given-names></name><name><surname>Cassatella</surname><given-names>MA</given-names></name></person-group>. <article-title>Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils</article-title>. <source>Immunol Lett</source> (<year>2008</year>) <volume>116</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.imlet.2007.11.009</pub-id><?supplied-pmid 18155301?><pub-id pub-id-type="pmid">18155301</pub-id></mixed-citation></ref><ref id="B295"><label>295</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Vinuesa</surname><given-names>CG</given-names></name></person-group>. <article-title>Pathophysiology of T follicular helper cells in humans and mice</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<fpage>142</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3054</pub-id><?supplied-pmid 25594465?><pub-id pub-id-type="pmid">25594465</pub-id></mixed-citation></ref><ref id="B296"><label>296</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linterman</surname><given-names>MA</given-names></name><name><surname>Rigby</surname><given-names>RJ</given-names></name><name><surname>Wong</surname><given-names>RK</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Brink</surname><given-names>R</given-names></name><name><surname>Cannons</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title>Follicular helper T cells are required for systemic autoimmunity</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>561</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20081886</pub-id><?supplied-pmid 19221396?><pub-id pub-id-type="pmid">19221396</pub-id></mixed-citation></ref><ref id="B297"><label>297</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>N</given-names></name><name><surname>Gatenby</surname><given-names>PA</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Malik</surname><given-names>S</given-names></name><name><surname>Fulcher</surname><given-names>DA</given-names></name><name><surname>Tangye</surname><given-names>SG</given-names></name><etal/></person-group>
<article-title>Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source> (<year>2010</year>) <volume>62</volume>:<fpage>234</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1002/art.25032</pub-id><?supplied-pmid 20039395?><pub-id pub-id-type="pmid">20039395</pub-id></mixed-citation></ref><ref id="B298"><label>298</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craft</surname><given-names>JE</given-names></name></person-group>. <article-title>Follicular helper T cells in immunity and systemic autoimmunity</article-title>. <source>Nat Rev Rheumatol</source> (<year>2012</year>) <volume>8</volume>:<fpage>337</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2012.58</pub-id><?supplied-pmid 22549246?><pub-id pub-id-type="pmid">22549246</pub-id></mixed-citation></ref><ref id="B299"><label>299</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolff</surname><given-names>S</given-names></name><name><surname>Quandt</surname><given-names>D</given-names></name><name><surname>Feldkamp</surname><given-names>T</given-names></name><name><surname>Jun</surname><given-names>C</given-names></name><name><surname>Mitchell</surname><given-names>A</given-names></name><name><surname>Hua</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-gamma production and altered IL-17 production in patients with systemic lupus erythematosus</article-title>. <source>Scand J Rheumatol</source> (<year>2014</year>) <volume>43</volume>:<fpage>307</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.3109/03009742.2013.869830</pub-id><pub-id pub-id-type="pmid">25088926</pub-id></mixed-citation></ref><ref id="B300"><label>300</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Upregulated PD-1 expression is associated with the development of systemic lupus erythematosus, but not the PD-1.1 allele of the PDCD1 gene</article-title>. <source>Int J Genomics</source> (<year>2014</year>) <volume>2014</volume>:<fpage>950903</fpage>.<pub-id pub-id-type="doi">10.1155/2014/950903</pub-id><?supplied-pmid 24860805?><pub-id pub-id-type="pmid">24860805</pub-id></mixed-citation></ref><ref id="B301"><label>301</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Ho</surname><given-names>JH</given-names></name><name><surname>Pasoto</surname><given-names>SG</given-names></name><name><surname>Bunin</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Carrasco</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity</article-title>. <source>Arthritis Rheumatol</source> (<year>2015</year>) <volume>67</volume>:<fpage>988</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1002/art.39020</pub-id><?supplied-pmid 25581113?><pub-id pub-id-type="pmid">25581113</pub-id></mixed-citation></ref><ref id="B302"><label>302</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffer</surname><given-names>L</given-names></name><name><surname>Worthmann</surname><given-names>K</given-names></name><name><surname>Haller</surname><given-names>H</given-names></name><name><surname>Schiffer</surname><given-names>M</given-names></name></person-group>. <article-title>CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis &#x02013; from bench to bedside?</article-title>
<source>Clin Exp Immunol</source> (<year>2015</year>) <volume>179</volume>:<fpage>85</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12439</pub-id><?supplied-pmid 25138065?><pub-id pub-id-type="pmid">25138065</pub-id></mixed-citation></ref><ref id="B303"><label>303</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>P</given-names></name><name><surname>Ueno</surname><given-names>H</given-names></name><name><surname>Schmitt</surname><given-names>N</given-names></name></person-group>. <article-title>T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>:<fpage>281</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201545760</pub-id><?supplied-pmid 26614103?><pub-id pub-id-type="pmid">26614103</pub-id></mixed-citation></ref><ref id="B304"><label>304</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>GW</given-names></name><name><surname>Hill</surname><given-names>DG</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name></person-group>
<article-title>Understanding immune cells in tertiary lymphoid organ development: it is all starting to come together</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>401</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00401</pub-id><pub-id pub-id-type="pmid">27752256</pub-id></mixed-citation></ref><ref id="B305"><label>305</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>ZS</given-names></name><name><surname>Rao</surname><given-names>SP</given-names></name><name><surname>Kalled</surname><given-names>SL</given-names></name><name><surname>Manser</surname><given-names>T</given-names></name></person-group>. <article-title>Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>1157</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20030495</pub-id><?supplied-pmid 14557413?><pub-id pub-id-type="pmid">14557413</pub-id></mixed-citation></ref><ref id="B306"><label>306</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coquery</surname><given-names>CM</given-names></name><name><surname>Loo</surname><given-names>WM</given-names></name><name><surname>Wade</surname><given-names>NS</given-names></name><name><surname>Bederman</surname><given-names>AG</given-names></name><name><surname>Tung</surname><given-names>KS</given-names></name><name><surname>Lewis</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>BAFF regulates follicular helper t cells and affects their accumulation and interferon-gamma production in autoimmunity</article-title>. <source>Arthritis Rheumatol</source> (<year>2015</year>) <volume>67</volume>:<fpage>773</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1002/art.38950</pub-id><pub-id pub-id-type="pmid">25385309</pub-id></mixed-citation></ref><ref id="B307"><label>307</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terawaki</surname><given-names>S</given-names></name><name><surname>Chikuma</surname><given-names>S</given-names></name><name><surname>Shibayama</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Okazaki</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>IFN-alpha directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>2772</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003208</pub-id><pub-id pub-id-type="pmid">21263073</pub-id></mixed-citation></ref><ref id="B308"><label>308</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayamada</surname><given-names>S</given-names></name><name><surname>Poholek</surname><given-names>AC</given-names></name><name><surname>Lu</surname><given-names>KT</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Iwata</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>2156</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1300675</pub-id><?supplied-pmid 24489092?><pub-id pub-id-type="pmid">24489092</pub-id></mixed-citation></ref><ref id="B309"><label>309</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>H</given-names></name><name><surname>Detjen</surname><given-names>AK</given-names></name><name><surname>Schuck</surname><given-names>SD</given-names></name><name><surname>Gutschmidt</surname><given-names>A</given-names></name><name><surname>Wahn</surname><given-names>U</given-names></name><name><surname>Magdorf</surname><given-names>K</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic>-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF</article-title>. <source>Cytokine</source> (<year>2008</year>) <volume>43</volume>:<fpage>143</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2008.05.002</pub-id><?supplied-pmid 18603443?><pub-id pub-id-type="pmid">18603443</pub-id></mixed-citation></ref><ref id="B310"><label>310</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tully</surname><given-names>G</given-names></name><name><surname>Kortsik</surname><given-names>C</given-names></name><name><surname>Hohn</surname><given-names>H</given-names></name><name><surname>Zehbe</surname><given-names>I</given-names></name><name><surname>Hitzler</surname><given-names>WE</given-names></name><name><surname>Neukirch</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Highly focused T cell responses in latent human pulmonary <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>2174</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.4.2174</pub-id><?supplied-pmid 15699149?><pub-id pub-id-type="pmid">15699149</pub-id></mixed-citation></ref><ref id="B311"><label>311</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephen-Victor</surname><given-names>E</given-names></name><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Das</surname><given-names>M</given-names></name><name><surname>Karnam</surname><given-names>A</given-names></name><name><surname>Saha</surname><given-names>C</given-names></name><name><surname>Lecerf</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IL-1beta, but not programed death-1 and programed death ligand pathway, is critical for the human Th17 response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>465</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00465</pub-id><pub-id pub-id-type="pmid">27867382</pub-id></mixed-citation></ref><ref id="B312"><label>312</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>JI</given-names></name><name><surname>Kviatcovsky</surname><given-names>D</given-names></name><name><surname>Romero</surname><given-names>MM</given-names></name><name><surname>Balboa</surname><given-names>L</given-names></name><name><surname>Monteserin</surname><given-names>J</given-names></name><name><surname>Ritacco</surname><given-names>V</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> multi-drug-resistant strain M induces IL-17+ IFNgamma-CD4+ T cell expansion through an IL-23 and TGF-beta-dependent mechanism in patients with MDR-TB tuberculosis</article-title>. <source>Clin Exp Immunol</source> (<year>2017</year>) <volume>187</volume>:<fpage>160</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12873</pub-id><pub-id pub-id-type="pmid">27681197</pub-id></mixed-citation></ref><ref id="B313"><label>313</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toossi</surname><given-names>Z</given-names></name><name><surname>Gogate</surname><given-names>P</given-names></name><name><surname>Shiratsuchi</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Ellner</surname><given-names>JJ</given-names></name></person-group>. <article-title>Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions</article-title>. <source>J Immunol</source> (<year>1995</year>) <volume>154</volume>:<fpage>465</fpage>&#x02013;<lpage>73</lpage>.<?supplied-pmid 7995958?><pub-id pub-id-type="pmid">7995958</pub-id></mixed-citation></ref><ref id="B314"><label>314</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olobo</surname><given-names>JO</given-names></name><name><surname>Geletu</surname><given-names>M</given-names></name><name><surname>Demissie</surname><given-names>A</given-names></name><name><surname>Eguale</surname><given-names>T</given-names></name><name><surname>Hiwot</surname><given-names>K</given-names></name><name><surname>Aderaye</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts</article-title>. <source>Scand J Immunol</source> (<year>2001</year>) <volume>53</volume>:<fpage>85</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-3083.2001.00844.x</pub-id><?supplied-pmid 11169211?><pub-id pub-id-type="pmid">11169211</pub-id></mixed-citation></ref><ref id="B315"><label>315</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothchild</surname><given-names>AC</given-names></name><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Nunes-Alves</surname><given-names>C</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group>. <article-title>iNKT cell production of GM-CSF controls <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1003805</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003805</pub-id><?supplied-pmid 24391492?><pub-id pub-id-type="pmid">24391492</pub-id></mixed-citation></ref><ref id="B316"><label>316</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Juarrero</surname><given-names>M</given-names></name><name><surname>Hattle</surname><given-names>JM</given-names></name><name><surname>Izzo</surname><given-names>A</given-names></name><name><surname>Junqueira-Kipnis</surname><given-names>AP</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Trapnell</surname><given-names>BC</given-names></name><etal/></person-group>
<article-title>Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Leukoc Biol</source> (<year>2005</year>) <volume>77</volume>:<fpage>914</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.1204723</pub-id><?supplied-pmid 15767289?><pub-id pub-id-type="pmid">15767289</pub-id></mixed-citation></ref><ref id="B317"><label>317</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeliga</surname><given-names>J</given-names></name><name><surname>Daniel</surname><given-names>DS</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Sever-Chroneos</surname><given-names>Z</given-names></name><name><surname>Jagannath</surname><given-names>C</given-names></name><name><surname>Chroneos</surname><given-names>ZC</given-names></name></person-group>
<article-title>Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2008</year>) <volume>88</volume>:<fpage>7</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2007.08.009</pub-id><pub-id pub-id-type="pmid">17928269</pub-id></mixed-citation></ref><ref id="B318"><label>318</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verreck</surname><given-names>FA</given-names></name><name><surname>De Boer</surname><given-names>T</given-names></name><name><surname>Langenberg</surname><given-names>DM</given-names></name><name><surname>Hoeve</surname><given-names>MA</given-names></name><name><surname>Kramer</surname><given-names>M</given-names></name><name><surname>Vaisberg</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2004</year>) <volume>101</volume>:<fpage>4560</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0400983101</pub-id><?supplied-pmid 15070757?><pub-id pub-id-type="pmid">15070757</pub-id></mixed-citation></ref><ref id="B319"><label>319</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verreck</surname><given-names>FA</given-names></name><name><surname>De Boer</surname><given-names>T</given-names></name><name><surname>Langenberg</surname><given-names>DM</given-names></name><name><surname>Van Der Zanden</surname><given-names>L</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation</article-title>. <source>J Leukoc Biol</source> (<year>2006</year>) <volume>79</volume>:<fpage>285</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0105015</pub-id><?supplied-pmid 16330536?><pub-id pub-id-type="pmid">16330536</pub-id></mixed-citation></ref><ref id="B320"><label>320</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tall</surname><given-names>AR</given-names></name><name><surname>Yvan-Charvet</surname><given-names>L</given-names></name></person-group>
<article-title>Cholesterol, inflammation and innate immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>104</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1038/nri3793</pub-id><pub-id pub-id-type="pmid">25614320</pub-id></mixed-citation></ref><ref id="B321"><label>321</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Low-density granulocytes are elevated in mycobacterial infection and associated with the severity of tuberculosis</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0153567</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0153567</pub-id><?supplied-pmid 27073889?><pub-id pub-id-type="pmid">27073889</pub-id></mixed-citation></ref><ref id="B322"><label>322</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Kichik</surname><given-names>V</given-names></name><name><surname>Mondragon-Flores</surname><given-names>R</given-names></name><name><surname>Mondragon-Castelan</surname><given-names>M</given-names></name><name><surname>Gonzalez-Pozos</surname><given-names>S</given-names></name><name><surname>Muniz-Hernandez</surname><given-names>S</given-names></name><name><surname>Rojas-Espinosa</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Neutrophil extracellular traps are induced by <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Tuberculosis (Edinb)</source> (<year>2009</year>) <volume>89</volume>:<fpage>29</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2008.09.009</pub-id><pub-id pub-id-type="pmid">19056316</pub-id></mixed-citation></ref><ref id="B323"><label>323</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>KW</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> exploits human interferon gamma to stimulate macrophage extracellular trap formation and necrosis</article-title>. <source>J Infect Dis</source> (<year>2013</year>) <volume>208</volume>:<fpage>109</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit097</pub-id><pub-id pub-id-type="pmid">23475311</pub-id></mixed-citation></ref><ref id="B324"><label>324</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>RJ</given-names></name><name><surname>Butler</surname><given-names>RE</given-names></name><name><surname>Stewart</surname><given-names>GR</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic> ESAT-6 is a leukocidin causing Ca2+ influx, necrosis and neutrophil extracellular trap formation</article-title>. <source>Cell Death Dis</source> (<year>2014</year>) <volume>5</volume>:<fpage>e1474</fpage>.<pub-id pub-id-type="doi">10.1038/cddis.2014.394</pub-id><?supplied-pmid 25321481?><pub-id pub-id-type="pmid">25321481</pub-id></mixed-citation></ref><ref id="B325"><label>325</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozza</surname><given-names>L</given-names></name><name><surname>Farinacci</surname><given-names>M</given-names></name><name><surname>Bechtle</surname><given-names>M</given-names></name><name><surname>Staber</surname><given-names>M</given-names></name><name><surname>Zedler</surname><given-names>U</given-names></name><name><surname>Baiocchini</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Communication between human dendritic cell subsets in tuberculosis: requirements for naive CD4(+) T cell stimulation</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>324</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00324</pub-id><?supplied-pmid 25071784?><pub-id pub-id-type="pmid">25071784</pub-id></mixed-citation></ref><ref id="B326"><label>326</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>O</given-names></name><name><surname>Kavikondala</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Mok</surname><given-names>MY</given-names></name><name><surname>Chan</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression</article-title>. <source>Lupus</source> (<year>2008</year>) <volume>17</volume>:<fpage>654</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1177/0961203308089410</pub-id><?supplied-pmid 18625638?><pub-id pub-id-type="pmid">18625638</pub-id></mixed-citation></ref><ref id="B327"><label>327</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtner</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>R</given-names></name><name><surname>Mengoni</surname><given-names>F</given-names></name><name><surname>Vignoli</surname><given-names>S</given-names></name><name><surname>Colacchia</surname><given-names>B</given-names></name><name><surname>Massetti</surname><given-names>AP</given-names></name><etal/></person-group>
<article-title>Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response</article-title>. <source>Clin Exp Immunol</source> (<year>2006</year>) <volume>143</volume>:<fpage>329</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02994.x</pub-id><?supplied-pmid 16412058?><pub-id pub-id-type="pmid">16412058</pub-id></mixed-citation></ref><ref id="B328"><label>328</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EB</given-names></name><name><surname>Yamada</surname><given-names>DH</given-names></name><name><surname>Elsaesser</surname><given-names>H</given-names></name><name><surname>Herskovitz</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title>. <source>Science</source> (<year>2013</year>) <volume>340</volume>:<fpage>202</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1126/science.1235208</pub-id><?supplied-pmid 23580528?><pub-id pub-id-type="pmid">23580528</pub-id></mixed-citation></ref><ref id="B329"><label>329</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>
<article-title>Autoimmunity: interferon alpha or beta: which is the culprit in autoimmune disease?</article-title>
<source>Nat Rev Rheumatol</source> (<year>2016</year>) <volume>12</volume>:<fpage>439</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2016.117</pub-id><pub-id pub-id-type="pmid">27411904</pub-id></mixed-citation></ref><ref id="B330"><label>330</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>TD</given-names></name><name><surname>Vosslamber</surname><given-names>S</given-names></name><name><surname>Mantel</surname><given-names>E</given-names></name><name><surname>De Ridder</surname><given-names>S</given-names></name><name><surname>Wesseling</surname><given-names>JG</given-names></name><name><surname>Van Der Pouw Kraan</surname><given-names>TC</given-names></name><etal/></person-group>
<article-title>Physiological evidence for diversification of IFNalpha- and IFNbeta-mediated response programs in different autoimmune diseases</article-title>. <source>Arthritis Res Ther</source> (<year>2016</year>) <volume>18</volume>:<fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s13075-016-0946-9</pub-id><pub-id pub-id-type="pmid">26882897</pub-id></mixed-citation></ref><ref id="B331"><label>331</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>CT</given-names></name><name><surname>Mendoza</surname><given-names>JL</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group>. <article-title>Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes</article-title>. <source>Cell</source> (<year>2016</year>) <volume>164</volume>:<fpage>349</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.12.027</pub-id><?supplied-pmid 26824652?><pub-id pub-id-type="pmid">26824652</pub-id></mixed-citation></ref><ref id="B332"><label>332</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccala</surname><given-names>R</given-names></name><name><surname>Welch</surname><given-names>MJ</given-names></name><name><surname>Gonzalez-Quintial</surname><given-names>R</given-names></name><name><surname>Walsh</surname><given-names>KB</given-names></name><name><surname>Teijaro</surname><given-names>JR</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Type I interferon is a therapeutic target for virus-induced lethal vascular damage</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>:<fpage>8925</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1408148111</pub-id><?supplied-pmid 24889626?><pub-id pub-id-type="pmid">24889626</pub-id></mixed-citation></ref><ref id="B333"><label>333</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>DB</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Seddiki</surname><given-names>N</given-names></name><name><surname>Waring</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2014</year>) <volume>94</volume>:<fpage>494</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2014.07.002</pub-id><pub-id pub-id-type="pmid">25095750</pub-id></mixed-citation></ref><ref id="B334"><label>334</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puthia</surname><given-names>M</given-names></name><name><surname>Ambite</surname><given-names>I</given-names></name><name><surname>Cafaro</surname><given-names>C</given-names></name><name><surname>Butler</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Lutay</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections</article-title>. <source>Sci Transl Med</source> (<year>2016</year>) <volume>8</volume>:<fpage>336ra359</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aaf1156</pub-id><?supplied-pmid 27122612?><pub-id pub-id-type="pmid">27122612</pub-id></mixed-citation></ref><ref id="B335"><label>335</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stohl</surname><given-names>W</given-names></name><name><surname>Hiepe</surname><given-names>F</given-names></name><name><surname>Latinis</surname><given-names>KM</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Scheinberg</surname><given-names>MA</given-names></name><name><surname>Clarke</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source> (<year>2012</year>) <volume>64</volume>:<fpage>2328</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1002/art.34400</pub-id><?supplied-pmid 22275291?><pub-id pub-id-type="pmid">22275291</pub-id></mixed-citation></ref><ref id="B336"><label>336</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>HB</given-names></name><name><surname>Joshi</surname><given-names>SK</given-names></name><name><surname>Rampuria</surname><given-names>P</given-names></name><name><surname>Devera</surname><given-names>TS</given-names></name><name><surname>Lang</surname><given-names>GA</given-names></name><name><surname>Stohl</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<fpage>1154</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1300263</pub-id><?supplied-pmid 23797666?><pub-id pub-id-type="pmid">23797666</pub-id></mixed-citation></ref><ref id="B337"><label>337</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e38429</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0038429</pub-id><?supplied-pmid 22719887?><pub-id pub-id-type="pmid">22719887</pub-id></mixed-citation></ref><ref id="B338"><label>338</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achkar</surname><given-names>JM</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Casadevall</surname><given-names>A</given-names></name></person-group>. <article-title>B cells and antibodies in the defense against <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>264</volume>:<fpage>167</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12276</pub-id><?supplied-pmid 25703559?><pub-id pub-id-type="pmid">25703559</pub-id></mixed-citation></ref><ref id="B339"><label>339</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>LL</given-names></name><name><surname>Chung</surname><given-names>AW</given-names></name><name><surname>Rosebrock</surname><given-names>TR</given-names></name><name><surname>Ghebremichael</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>WH</given-names></name><name><surname>Grace</surname><given-names>PS</given-names></name><etal/></person-group>
<article-title>A functional role for antibodies in tuberculosis</article-title>. <source>Cell</source> (<year>2016</year>) <volume>167</volume>:<fpage>433</fpage>&#x02013;<lpage>43.e14</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.08.072</pub-id><?supplied-pmid 27667685?><pub-id pub-id-type="pmid">27667685</pub-id></mixed-citation></ref><ref id="B340"><label>340</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Del Nonno</surname><given-names>F</given-names></name><name><surname>Baiocchini</surname><given-names>A</given-names></name><name><surname>Petrone</surname><given-names>L</given-names></name><name><surname>Vanini</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005687</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005687</pub-id><?supplied-pmid 27304615?><pub-id pub-id-type="pmid">27304615</pub-id></mixed-citation></ref><ref id="B341"><label>341</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thien</surname><given-names>M</given-names></name><name><surname>Phan</surname><given-names>TG</given-names></name><name><surname>Gardam</surname><given-names>S</given-names></name><name><surname>Amesbury</surname><given-names>M</given-names></name><name><surname>Basten</surname><given-names>A</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches</article-title>. <source>Immunity</source> (<year>2004</year>) <volume>20</volume>:<fpage>785</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2004.05.010</pub-id><?supplied-pmid 15189742?><pub-id pub-id-type="pmid">15189742</pub-id></mixed-citation></ref><ref id="B342"><label>342</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toubi</surname><given-names>E</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Kessel</surname><given-names>A</given-names></name><name><surname>Rosner</surname><given-names>I</given-names></name><name><surname>Rozenbaum</surname><given-names>M</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity</article-title>. <source>J Autoimmun</source> (<year>2006</year>) <volume>27</volume>:<fpage>134</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaut.2006.07.005</pub-id><?supplied-pmid 17029886?><pub-id pub-id-type="pmid">17029886</pub-id></mixed-citation></ref><ref id="B343"><label>343</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francois</surname><given-names>A</given-names></name><name><surname>Gombault</surname><given-names>A</given-names></name><name><surname>Villeret</surname><given-names>B</given-names></name><name><surname>Alsaleh</surname><given-names>G</given-names></name><name><surname>Fanny</surname><given-names>M</given-names></name><name><surname>Gasse</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis</article-title>. <source>J Autoimmun</source> (<year>2015</year>) <volume>56</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaut.2014.08.003</pub-id><?supplied-pmid 25441030?><pub-id pub-id-type="pmid">25441030</pub-id></mixed-citation></ref><ref id="B344"><label>344</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrichs</surname><given-names>T</given-names></name><name><surname>Kosmiadi</surname><given-names>GA</given-names></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Pradl</surname><given-names>L</given-names></name><name><surname>Titukhina</surname><given-names>M</given-names></name><name><surname>Mishenko</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma</article-title>. <source>J Infect Dis</source> (<year>2005</year>) <volume>192</volume>:<fpage>89</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1086/430621</pub-id><?supplied-pmid 15942898?><pub-id pub-id-type="pmid">15942898</pub-id></mixed-citation></ref><ref id="B345"><label>345</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moguche</surname><given-names>AO</given-names></name><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Clemons</surname><given-names>C</given-names></name><name><surname>Larson</surname><given-names>RP</given-names></name><name><surname>Dinh</surname><given-names>C</given-names></name><name><surname>Higdon</surname><given-names>LE</given-names></name><etal/></person-group>
<article-title>ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>:<fpage>715</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20141518</pub-id><?supplied-pmid 25918344?><pub-id pub-id-type="pmid">25918344</pub-id></mixed-citation></ref><ref id="B346"><label>346</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>KW</given-names></name><name><surname>Dugast</surname><given-names>AS</given-names></name><name><surname>Alter</surname><given-names>G</given-names></name><name><surname>Mcelrath</surname><given-names>MJ</given-names></name><name><surname>Stamatatos</surname><given-names>L</given-names></name></person-group>. <article-title>HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>2769</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1400952</pub-id><?supplied-pmid 25667414?><pub-id pub-id-type="pmid">25667414</pub-id></mixed-citation></ref><ref id="B347"><label>347</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><etal/></person-group>
<article-title>Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis</article-title>. <source>Eur J Immunol</source> (<year>2011</year>) <volume>41</volume>:<fpage>1941</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201141421</pub-id><?supplied-pmid 21509782?><pub-id pub-id-type="pmid">21509782</pub-id></mixed-citation></ref><ref id="B348"><label>348</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sage</surname><given-names>PT</given-names></name><name><surname>Francisco</surname><given-names>LM</given-names></name><name><surname>Carman</surname><given-names>CV</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name></person-group>. <article-title>The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>152</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2496</pub-id><?supplied-pmid 23242415?><pub-id pub-id-type="pmid">23242415</pub-id></mixed-citation></ref></